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Using computational tools to solve various biological problems has become common
practice over the last decade. This has been primarily fueled by exponentially growing high
throughput biological data and relevant computational biology resources to support it [1]. The
work presented in this thesis showcases application of computational techniques to answer
critical biological questions pertaining to gene family evolution and single cell gene expression
analysis.
Dr. Susumu Ohno was a pioneer to propose the significance of gene duplication in
driving gene family evolution. Gene duplication has been shown to expand the repertoire of
several gene families involved in multitude of important biological functions. Thus,
understanding the forces that lead to retention and loss of gene duplicates have been subject
to close scrutiny over the past decade. One of the works presented in this thesis provides a
strong argument for a novel gene duplication model that seeks to explain retention of
previously unexplained gene duplicates. The first part of the work involved an in-depth study of
evolutionary history of mammalian ribosomal protein gene family (RPG) evolution. This study
confirmed our prior preliminary finding that there are thousands of intact duplicates whose fate
could not be explained by existing gene duplication models. This led us to frame a novel gene
duplication model that explains the retention of these gene duplicates. We also make a strong
case for this model by employing rigorous in-silico and in-vitro tests to demonstrate its
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feasibility. We have achieved a rare feat by employing the above-mentioned two orthogonal
but necessary tests that are lacking in other gene duplication models.
Our investment in studying RPG family evolution enabled us to frame a novel single cell
RNA-Seq (scRNA-Seq) QC pipeline. We hypothesized that the biological constraints under which
RPGs function could serve as a robust biological indicator for cell health at single cell resolution.
We formulated an outlier based QC model consisting of three features that could be extracted
from RPG transcriptional signatures in any scRNA-Seq dataset. We show stable performance of
the model across various datasets along with comparison with other QC features widely used in
existing approaches. This QC model is designed to be easily implemented and applied to any
scRNA-Seq study irrespective of experimental approach.
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Chapter 1: Introduction to Gene Family Evolution
1.1 Evolution of gene families through gene duplication
Gene duplication has been shown to be a major driving force in evolution of gene families and
organismal complexity [2]. Dr. Susumu Ohno was a pioneer to recognize the importance of gene
duplication and he hypothesized that it provided raw material necessary for diversification of gene
function [3]. Rightly so, it is now well established that gene duplication has played a major role in giving
rise to complex gene families like HOX, WNT, FGF etc., which perform important functions in higher
eukaryotes. Recent data reveal that lineage-specific expansion and contraction of gene families is more
rapid than previously appreciated, and is responsible for major differences in gene family size between
closely related mammalian genomes. These turnover events are likely to have been major contributors
to divergence of mammalian lineages and human evolution [4]. Given the vital role of gene duplication
in shaping major evolutionary changes, it is imperative to understand the forces that lead to retention or
loss of duplicated genes.

1.2 Gene Duplication Mechanisms
Duplications in the genome are typically found at varying lengths from a single nucleotide to the
entire genome. Gene duplication is defined as a duplication of a region in the genome that contains a
gene. In this context, the major mechanisms that give rise to gene duplicates would be i) Tandem
Duplication, ii) DNA Transposition, iii) Whole-Genome duplication and iv) Retro-transposition [5]. The
first three mechanisms are DNA based duplications; hence there is a high probability for the regulatory
apparatus to be copied along with the gene. Most well-known / well characterized gene families such as
Hox, Wnt etc., have been shown to evolve through DNA-based duplicates. This has led to gene
duplication being generally associated with DNA-based mechanisms. Yet, in recent studies over the

1

decade, there has been considerable evidence of functional contribution of RNA based duplicates which
arise through retro-transposition [6]. In this case, mRNA molecules in the cell are reverse transcribed
and the resulting cDNA copy is randomly integrated in the genome. These duplicates lack regulatory
sequences and thus predicted to be “dead on arrival”. On the contrary, due to rampant events of retrotranspositions compared to other DNA-based duplications, some of these duplicates have fortuitously
acquired expression by either landing in a transcriptionally active region in the genome or acquiring
promoter activity from neighboring genes [7].

1.3 Models for Gene Duplication
Gene duplication first occurs in a single member within a population (in the germline to be passed
on to the next generation) and thus extremely vulnerable to early stochastic loss. For long term
retention of the duplicate i.e. fixed in the population, it must occur at high frequency in the population
and come under the influence of sufficiently large selective forces to preserve it from loss by
degenerative mutations. Thus, understanding the retention of duplicates is key to comprehending
dynamics of genome evolution. During the 1970s, Dr. Susumo Ohno elucidated that gene duplicates are
retained in the genome through three distinct evolutionary trajectories, namely i) Conservation:
Duplicates are conserved to modulate gene dosage, ii) Sub-functionalization: Gene function is
partitioned amongst the duplicates and iii) Neo-functionalization: Gene duplicates evolve a novel
function. Since then, numerous validations and extensions have been shown in support of these above
mentioned models. These models will be discussed in detail in Chapter 3.

1.4 Retro-duplication in mammals
Retro duplication has been an understudied topic due to aforementioned perception of having a
non-functional role. Over the past two decades, increase in availability of genomic data from various
mammalian species and subsequent development of necessary analytical tools [8], has led to
2

comprehensive characterization of retroduplicates (RT) and study of its evolutionary trajectory [6,9].
Previously, we reported that conserved retroduplicates are widespread in mammals, representing half
of all gene duplicates under purifying selective pressure [10,11]. In addition, we noted that individual
gene families have a strong tendency to evolve via DNA-mediated or RNA-mediated duplication, but not
both. Developmentally important classes of genes, such as transcription factors, which often require
large amounts of regulatory information to function properly, tend to evolve through DNA-mediated
events. However, gene families involved in metabolic processes, such as protein synthesis, evolve
primarily through RNA-mediated duplication. In fact, we reported that ribosomal protein (RP) genes are
the largest class of conserved, retroduplicated genes in mammals [10]. While it is not surprising that the
highly abundant ribosomal protein transcripts appear to be more frequently captured by retroviral
reverse transcriptase than less abundant transcripts, it is intriguing that the slowly-evolving, highlyconserved ribosomal proteins have hundreds of intact duplicates in the genome.

1.5 Known examples of retrotransposed duplicates
One of the most prominent examples of a RNA-mediated duplicate is Fgf4, a retrogene associated
with the breed-defining chondrodysplasia in domestic dogs [12]. A human-specific example is the
C1orf37-duplicate, derived through retrotransposition after divergence of human from chimp;
expressed selectively in certain human tissues, such as brain. It is suggested to encode a novel
transmembrane protein [13]. Similar examples include TRMT12 retrogene [14], IMP3 gene [15,16] and
other such retrogenes (see [17–21]). The majority of the aforementioned RT genes follow the
convention that most retrogenes are in a state of ‘‘relaxed’’ selection. The molecular evolution of
retrogenes is selectively neutral, allowing them to freely mutate, giving them a chance to be inactivated
or positively selected, while parental genes remain subjected to purifying selection [22,23].

3

1.6 The Mammalian Ribosome and Ribosomal Proteins
The ribosome is an ancient molecular machine that is responsible for production of protein in all
living cells. The mammalian ribosome consists of 79 RPs and four rRNAs. RPs play a central role in
protein synthesis, are expressed at high levels, and evolve very slowly [24] showing strong conservation
across the three domains of life [25]. Proper ribosomal biogenesis requires equimolar production of all
RPs and rRNAs [25,26]. These transcriptional regulatory constraints have been extensively elucidated in
various studies [27,28], along with the evidence that different ribosomal protein promoters exhibit
equipotent strength [29]. Additionally, a strict copy number constraint is also observed as the majority
of full length RPs have been shown to be single copy genes [30].
Due to the necessity of protein synthesis in any living cell, and the complexity of ribosome structure
and assembly, it is perhaps unsurprising that mutations in ribosomal genes almost inevitably lead to
pathological conditions such as Minutes in Drosophila [31] and Diamond-Blackfan anemia (DBA) in
humans [32,33]. Despite, or perhaps because of, their stringent conservation, the evolution of RPs in
vertebrates is relatively understudied.

1.7 Known Examples of Mammalian Ribosomal Protein Duplicates
One of the most recently published DNA-mediated ribosomal protein (DD-RP) gene duplicates is
RPL22L1, paralog of ribosomal protein RPL22. These mouse paralogs play essential, distinct, and
antagonistic roles in hematopoietic development [34]. Another known rodent-specific RNA-mediated
ribosomal protein (RT-RP) gene duplicate is Rps23rg1, a gene originating from a retrotransposition of
Rps23 mRNA that encodes proteins that decrease Alzheimer’s β-amyloid level and tau phosphorylation
[35]. There is also evidence for a ubiquitously expressed RT-RP duplicate, Rpl36al, and testis-specific
RPL10L duplicate that have been implicated in compensation for the reduced dosage of X-linked RP
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genes [36]. RPL3L is a DD-RP duplicate that has been observed to be highly expressed in a group of
tissues where parent RPL3 has very little expression, exhibiting a potential functional role [28,37].

1.8

Prior work and scope of the study
Dr. Jin Jun and Dr. Craig Nelson from our lab investigated the contribution of DNA and RNA

mediated duplicates in evolution of mammalian gene families. They developed computational tools and
pipelines to enable this study. As mentioned earlier, two interesting and unexpected discoveries were
made based on their analyses, i) Half of all the conserved duplicates (across 5 mammalian species) are
retroduplicates, ii) Members of the ribosomal protein genes (RPGs) constitute the largest class of
conserved retroduplicated genes.
In a recently conducted study (Chapter 2), we address several questions about gene duplication
and the evolution of RPGs. Many research groups have studied the dynamics of gene duplication in RPs
in non-mammalian systems such as yeast [38]. In addition, some research has focused on individual
human ribosomal proteins and their duplicates (eg: RPS19 and RPL7a) or comparative analyses between
mammals [9,27,39,40]. To date, however, no study has encompassed all 79 mammalian RPs in a large
set of mammalian genomes. In order to fill this gap and more thoroughly annotate RP gene duplication
events during mammalian evolution, we created a pipeline that utilizes local synteny and conserved
intron content to (1) identify each duplicated RP gene in eight mammalian species, (2) place each
duplication event within the mammalian phylogeny, (3) discriminate between RNA- and DNA- mediated
duplications, (4) estimate the degree of purifying selective pressure exerted on every duplicated RP
gene, and (5) determine whether each duplicated RP gene copy exhibits evidence of expression.
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Chapter 2: Tempo and Mode of Gene Duplication in Mammalian
Ribosomal Protein Evolution
2.1 Computational pipeline to reconstruct mammalian RP Gene Families
2.1.1 Ribosomal Dataset
Seventy-six ribosomal protein (RP) sequences from nine species [human, chimp, monkey,
mouse, rat, dog, cow, opossum, and chicken (outgroup)] were manually collected from Ensembl 62 [51].
Three RPs were excluded due to annotation issues. When a single gene encoded multiple transcripts,
the longest was used. These protein sequences served as seed sequences, or input, to the pipeline
(Figure 1).
2.1.2 Extraction of Gene Family Members
RP seed sequences were submitted to tBLASTn against donor genomes to capture as many
putative duplicates of the seed gene as possible. Each resulting putative duplicate was processed using
Pseudopipe [8] to determine the mechanism of duplication (DNA- or RNA-mediated) and the fate of the
duplicate (intact or pseudogene). The default Pseudopipe filters for tBLASTn hits (E-value cutoff ≤ 10-4
and identity ≥ 40%) were used to define putative duplicates. Ambiguous duplicates, where the
duplication mechanism was not confirmed, were resolved using an intron comparison algorithm [10],
which compares intron/exon structure within a group while accounting for exon fusions and large
insertions in exonic regions. These methods generated a set of RP superfamilies that consist of both
protein-coding genes and related pseudogenes.
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Figure 1 - Pipeline for ribosomal protein family analyses. Protein sequence for all source ribosomal proteins were
collected manually from Ensembl62. These were input to tBLASTn against whole genomes to capture all putative
duplicates. The resulting duplicates were processed by Pseudopipe to determine the mechanism of duplication (DNA
or RNA) and the fate of the duplicate (intact or pseudogenized). We then utilized our in-house pipeline steps of
hierarchical clustering by local synteny [10] in order to build our gene family trees after filtering false-positives and
redundant entries. Final gene family analyses were conducted in 2 steps: 1) calculating the selective pressures on all
gene duplicates using the Nei-Gojobori method against the species- and family-specific seed protein via an exonbased reconstruction, and 2) checking for expression signatures via EST analyses using the UCSC genome browser EST
track for both human and mouse.

2.1.3 Identification of Duplications and Phylogenetic Analysis
Orthologous and paralogous relationships were determined using local synteny and a
hierarchical clustering algorithm described in Jun et al., 2008 [10,11]. A local synteny score was assigned
to all gene pairs based on the homology of genes (three upstream and three downstream) neighboring
the two query genes. Pairwise synteny measures were obtained for all members of a gene family. The
output generated based on these scores was used to construct phylogenetic trees in Newick format,
7

representing the history of duplication in each family. Parsimony [41] was used to assign each inferred
duplication event to a specific branch of the species tree [42,43]. ‘Tube’-style phylogenetic trees for 74
mammalian RP genes were used to illustrate the history of DNA/RNA-mediated duplications across
various evolutionary time periods (ancient vs. lineage specific) (See Appendix 1 for all trees).
2.1.4 Conservation and EST Analyses
Using exon-based reconstruction and the Nei Gojobori method, Ka/Ks ratios for all members of a
gene family were calculated against the seed proteins. The putative exon-intron structures of duplicates
were generated with an in-house algorithm, using these seed proteins. Results were then filtered based
on p-values (<0.1) and the fraction of the parental gene represented by each duplicate (>65%). Pairwise
distances using ClustalW were also calculated as an added metric to evaluate sequence identity and
account for all nucleotide level substitutions. Additionally, we also determined branch-wise omega
values for 28 ribosomal protein families with following parameters, model=2 & Nsite=0, using codeML in
PAML 4.7 [44]. In order to confirm the selective pressures, standard codon models M0, M1a, M2a were
fitted to the data set with codeML. We used likelihood ratio tests (LRT) to determine the relative fit of
the hierarchically nested models. Log likelihood ratio test statistic is 2Δℓ = 2(ℓ1 - ℓ0), where ℓ1 is the
log-likelihood of the model corresponding to the alternative hypothesis and ℓ0 represents the loglikelihood corresponding to the model used as null hypothesis. These values were compared with a chisquared distribution in which the difference between the number of parameters of both models
provides the degrees of freedom (df) [45,46]. Log likelihood values and parameter estimates are
detailed in the results section and supplementary material (Appendix 3). In order to determine if
duplicates were actively transcribed, human and mouse expressed sequence tags (EST) were mined
from the UCSC genome browser. ESTs that mapped to multiple locations or showed less than 95%
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identity or less than 95% fraction length were discarded. Additionally, EST presence & absence calls
were also made using data mined from Bgee database for annotated duplicates in our dataset [47].

2.2 Results from the analysis pipeline
2.2.1 76 Ribosomal Protein Family Member Analyses
The first step of our pipeline identified all detectable duplicates of RP genes in eight mammalian
genomes. RP families included 14,552 gene duplicates in the eight genomes analyzed: human, chimp,
monkey, mouse, rat, dog, cow, and opossum (Figure 2A). Although data in figure 2A include duplicates
with shared ancestry, the counts for each species represent the number of duplicate genes present in
each extant species. To determine if sequencing coverage had a significant impact on our detection of
RP gene duplicates, we compared the depth of sequence coverage in each species’ genome to the
number of duplications recovered in that species. We found no significant correlation between the
number of duplications and genome coverage (Pearson’s r=-0.353, p=0.391, Figure 2B). We also tested
for bias in duplication types in each species and found no species-specific bias in duplication
mechanisms (Figure S2). As we found significant association between species (p=6.07e-17, two-way chi
square test, Figure2B), all species were grouped for subsequent analyses.
Next we assessed the fate of each duplicate. Of the 14,552 duplicates detected, only 28 were
DNA-mediated (DD) duplicates; the remainder (99.8%) are RNA- mediated (RT) duplicates.
Approximately 88% of RNA-mediated duplicates are pseudogenes (12,800 duplicates), while 12% are
intact (1724 duplicates, Figure 2C). We also examined every ribosomal protein gene’s duplication history
and evolutionary trajectory in the context of the species tree. One example of the resulting information
is shown in Figure 3, for the ribosomal protein gene RPL36A. All 74 ribosomal protein gene family history
trees are attached in supplementary material (Appendix 1). Hereafter, all the intact RNA-mediated
ribosomal protein gene duplicates will be referred to as RT-RPs, intact DNA-mediated copies as DD-RPs
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and RNA-mediated pseudogenes as R-RPs. Leveraging previously published data by Jun et al., we
observed a clear overrepresentation of RT-RPs among 8,872 gene families analyzed (Figure S1).

Figure 2 - RP gene duplicates in 8 mammalian genomes. A) Distribution of duplicates in 8 mammalian genomes. B)
Assessment of coverage or species-specific bias in ribosomal protein gene duplicates. C) Representation of DNA and
RNA-mediated duplications in RP gene families. Abbreviations: Hs, Homo sapiens (human); Pt, Pan troglodytes
(chimpanzee); Mmul, Macaca mulatta (Rhesus macaque); Mm, Mus musculus (house mouse); Rn, Rattus norvegicus
(Norway rat); Bt, Bos taurus (cattle); Cf, Canis familiaris (dog); Md, Monodelphis domestica (gray short-tailed
opossum); Gg, Gallus gallus (chicken).
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2.2.2 The Fate of Ribosomal Protein Duplications over time
In the second step of our pipeline, we determined the probable location of each RP duplication
event in evolutionary history of these eight species, and distinguished between RNA- and DNAmediated duplication events (Figure 3; [10] ). Based on our methodology, Figure 4 clearly shows that the
majority of detectable duplications have occurred during recent mammalian evolution: 100 million years
ago (MYA) or more recently. However, a significant number of duplications date between 100–300 MYA.
The majority of RP gene duplications older than 90 MYA result in R-RPs (190), though some events (25)
are RT-RPs, and a very small number (4) are linked to DD-RPs [data not shown for DD-RPs due to small
sample size]. It is important to note that many of the more ancient duplications detected represent
incomplete clades; therefore we infer a considerable amount of gene loss. However, our inability to
detect these genes may also be due to loss of synteny or other limitations of our pipeline. The majority
of duplicates (N=13,588) observed in our dataset are young (91 MYA or younger). However, a few RTRPs and DD-RPs have been conserved in all (or most) of the eight mammalian species analyzed (see the
base of the tree in Figure 4).

11

Figure 3 – Example of the inferred evolutionary history for duplications of the ribosomal protein gene Rpl36a.
Grey outlined tube tree represents the species tree that includes 8 mammals and chicken. Source intron-bearing
gene (in blue). RT-RPs (clear triangles), R-RPs (grey triangles). An RT-RP duplicate generated from one of these
events, Rpl36al (in red, at the base of the mammalian lineage on the branch between LCA with opossum and the
other mammals) is conserved in all descendent species. All the 74 ribosomal protein gene family history trees are
attached in Appendix 1.
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Figure 4 - Ribosomal Protein Family duplication events based on age. All RP gene duplication events are displayed
for 8 mammalian species. The bar charts at all speciation nodes show events classified by fate of duplication. The
duplication counts on the bar charts are log normalized. RT-RPs are shown in red and R-RPs in green. DD-RPs are
not shown due to a very small sample size. The numbers above the bar charts represent the total number of gene
duplication events at that speciation node. Age is marked at the bottom of the tree in millions of years (age estimates
from [42,48]).
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2.2.3 Analysis of Selective Pressure Acting on All Ribosomal Gene Duplicates
To gain insight into the forces shaping the fate of these RP gene duplicates,
nonsynonymous/synonymous substitution rates were evaluated using pair-wise and branch-wise
methods (see 2.1.4 and [49–51]). For the pair-wise method, we observe that DD-RP dups and RT-RP
dups have mean Ka/Ks values of 0.166 (95% CI 0.083, 0.248) and 0.295 (95% CI 0.285, 0.305) suggesting
that they are under strong purifying selective pressure. R-RPs were under relatively less purifying
selective pressure with a mean value of 0.455 (95%CI 0.453, 0.458) (Figure 5A). In order to avoid false
positives with Ka/Ks >1, we did not include cases that had very low Ka and Ks values. Calculation of
pairwise DNA sequence distances reveals that the mean sequence distance for DD-RP duplicates was
0.091 (95% CI 0.062, 0.118), for RT-RP duplicates was 0.0059 (95% CI 0.062, 0.118) and for R-RPs was
0.172 (95% CI 0.169, 0.173).
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Figure 5 – Selective Pressures on Ribosomal Protein Gene Duplicates. A) Mean Ka/Ks ratios were calculated for all
classes (DD-RPs, RT-RPs and R-RPs) of RP gene duplicates using the Nei Gojobori method. Results were then filtered
based on p-values (< 0.1) and the fraction of the source gene represented by each duplicate (> 65%). Error bars
represent 95% confidence interval. B) Box and whisker plots for RT-RPs (blue) and R-RPs (green) were generated
for inner speciation nodes and C) Extant Species. DD-RPs were not included in the analyses due to small sample size
(N=3).
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This corroborates the evidence from the Ka/Ks analysis suggesting that these sequences are
under strong selective pressure (Figure S3). Next, we compared selective pressures on all RT-RP
duplicates of various ages in each lineage. (DD-RPs were not included in this analysis due to the very
small dataset.) Box-Whisker plots (Figure 5B and 5C) showed that RT- RP duplicates at all speciation
nodes, irrespective of their age or lineage, are under strong selective pressures, as determined by Ka/Ks
values. However, chimp (Pt) values seem to be an exception, likely due to a small sample size (Figure
5B). The trends appeared similar for all R-RPs as the median Ka/Ks values are similar (~0.45) for all
ages. Additionally, we also provide scatterplots for all speciation nodes to confirm the strong selection
on all RP duplicates irrespective of age (see figures S6 and S7). While pairwise Ka/Ks calculations are
computationally rapid and provide a good screen for selective pressure, especially within a gene family,
for added support we wanted to cross-check our estimates of selective pressure using branch-specific
omega values. To do this we used PAML to calculate branch-specific omega values for a sub-sample of
28 RP gene families (see Table S2). An example RP gene tree with all PAML branch-specific omega values
is shown in Figure S4. Using this approach, we obtained Ka/Ks values for RT-RP duplicates (mean =0.162,
95% CI 0.137, 0.188), and for the R-RPs (mean =0.357, 95% CI 0.347, 0.367). As previously mentioned,
to avoid false positives with Ka/Ks > 1, we excluded cases with very low Ka and Ks values. Both pairwise
and PAML-based estimation methods confirm the strong purifying selective pressure acting on RT-RPs
(Ka/Ks < 0.3) and a slightly lower pressure on R-RPs (Ka/Ks < 0.5).
As evolutionary pressure is often time dependent, we also plotted Ka against Ks estimated by
both pair-wise (Figure 6A) and branch-wise (Figure 6B) methods. As expected the branch-wise method
estimates higher divergence, as seen by the large distribution of Ks values (Figure 6B) compared to
pairwise method.
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Figure 6 –Scatterplots for pair-wise and branch-wise Ka against Ks values show that both methods capture the
strong selective pressure acting on the RP gene duplicates. Plot of Ka against Ks for RP families with branch-wise
and pair-wise methods. A) Distribution for all 76 RP families using the pair-wise selective pressure calculation
method. Red dots represent RT-RPs and green dots represents RΨ-RPs. The black solid line represents Ka=Ks and
the red & green line are the best line of fits for the distribution of RT-RPs and RΨ-RPs respectively. B) Distribution
for 28 RP families analyzed by codeml program in PAML. C) Distribution of the aforementioned 28 families from
PAML analysis using the pair-wise method.
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The influence of strong purifying selection over time is readily observed in Ka values for both methods as
the data points of RT-RPs are compressed near the origin relative to R-RPs, which have a much wider
distribution (Figure 6). In order to further confirm the nature of the selective pressure acting on our RTRPs and R-RPs, we also used different codon-substitution models developed by Nielsen and Yang [62]
and Yang et al. [58]. Random-site models M0, M1a and M2a which assume variation in ω among sites
but not among lineages were fitted to our data. The models used, parameter estimates and loglikelihood values are shown in Table S3. Table 1 shows the results of the LRT tests for these models. We
applied the simplest of site-based models M0 [30], which assume a uniform ω ratio for all codons, to
four random ribosomal genes namely Rps16, Rps18, Rpl14 and Rpl28. The estimated single ω value for
each of these trees ranges from 0.22 to 0.35 (Table S3). These values can be interpreted as an average of
all lineages in the tree and over all sites in the protein. The low ω range obtained indicates a strong
action of purifying selection in the evolution of ribosomal gene duplicates studied. To test if branchspecific omegas are statistically justified, we compared Model M1a (nearly neutral), which constrains
Ka/Ks ≤ 1 but not positive selection (Ka/Ks > 1) and M2a which allows for positive selective pressure.
This comparison leads us to reject the nearly neutral model as seen in Table 1. Our final comparison was
model M1a vs. M0 with a fix omega =1 and we find out that model M1a fits our data better (p-value <
0.0001). These results confirm that purifying selection is the predominant force acting in the evolution
of ribosomal protein genes. Therefore, it further validates the Ka/Ks values obtained from both pair-wise
and branch-wise methods.
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2.2.4 EST Analysis for human and mouse RP duplicate genes
EST data for human and mouse were mined in the final step of our analysis pipeline. Using very
stringent constraints; as mentioned before, we found evidence of expression for approximately 8% of all
human and mouse duplicates. It should be noted that in order to avoid false positives resulting from the
strong sequence similarity between parent genes and duplicates, a large number of EST matches were
filtered out, suggesting that our estimates of active transcription are likely underestimates. The majority
of EST data results from duplicates arising along younger portions of the mammalian lineage (younger
primate or rodent lineage or the mouse, hominoid and human branches (Figure 7A)). For example, 320
out of 335 ESTs are either primate-specific or mouse-specific. Finally, we compared the selective
pressure on all RT-RP duplicate genes with evidence of expression (in the form of EST matches) to those
without matching EST data. DD-RPs were not analyzed due to the small sample size (N = 3). Expressed
RT-RP duplicates exhibit significantly higher levels of purifying selection than their non-transcribed
counterparts (mean Ka/Ks value of 0.12 (95% CI 0.09, 0.15) compared to 0.24 (95% CI 0.22, 0.26)
respectively (Figure 7B)).
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Figure 7 - Human/Mouse EST Counts and evolutionary selective pressure. A) Counts of human and mouse genes
with EST (green) versus NO EST (blue) at all speciation nodes were calculated. B) Ka/Ks values were calculated for
RT-RPs and R-RPs for gene duplicates with (green) and without expression (blue). C) Pairwise distances for RTRPs and R-RPs with and without expression.
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However, no similar difference in selective pressure is observed between expressed R-RPs, whose
mean Ka/Ks value is 0.36 (95% CI 0.31, 0.41), and their nontranscribed counterparts (mean Ka/Ks value
of 0.35 (95% CI 0.34, 0.36)) (Figure 7B). Similarly, pairwise sequence distances for these duplicated
genes show that expressed RT-RP duplicates (mean pairwise distance of 0.02 (95% CI 0.01, 0.03)) have
diverged less than intact non-transcribed duplicates (pairwise distance of 0.06 (95% CI 0.05, 0.07))
(Figure 7C). However, just as in the Ka/Ks analysis above, expressed R-RPs have diverged less than
non-transcribed pseudogenized duplicates (0.09 (95% CI 0.06, 0.13)) compared to 0.16 (95% CI 0.15,
0.17) (Figure 7C). It is interesting to note that mean pairwise sequence distances are lower for
pseudogenes with ESTs, suggesting purifying selective pressure prior to the pseudogenization event.

2.3 Discussion
Here we provide a near-comprehensive study of ribosomal protein gene sequence evolution,
duplication, and loss in eight mammalian species. We find that these highly-conserved and highlyexpressed genes are, not unexpectedly, frequently duplicated by retrotransposition, and comprise the
largest such class of genes in mammalian genomes. It is quite clear that RNA-mediated RP duplicates
(14,524 out of 14,552 total duplicates) dominate RP gene families. There is rare evidence of an old DNA
duplicate, RPL3L (see Appendix 1) that has been retained for function (see [28,52]). However, the
presence of only a very few such old duplicates and a complete absence of recent DD-RP duplicates,
implies selection against the retention of DNA-mediated RP duplications. Negative selection against
DNA-duplicates combined with the abundance of ribosomal protein gene mRNAs, and the observation
that reverse transcription and transposition are more efficient on short GC-poor sequences like the
ribosomal mRNAs [40,53], likely explain the almost complete dominance of retroduplication events in
the evolution of the mammalian ribosomal protein genes.
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Less expectedly, we also find that many of these retrotransposed RP duplicates are under strong
purifying selective pressure (N=1,724), and that this pressure is greatest amongst transcribed RP
retroduplicates, regardless of whether these duplicates have been pseudogenized or retain intact coding
regions. As gene duplicates are often found to be under relaxed selective pressures [5,23,54], the
strength of selective pressure we observe across RT-RP duplicates was unexpected. It was not
immediately obvious to us why so many duplicates are under selective pressure when the parental
ribosomal genes exist almost exclusively in single copy, when DNA-mediated duplications appear to be
selected against, where RP transcript levels are tightly regulated for optimal fitness, and the duplications
are occurring over a timeframe where ribosomal evolution is thought to be almost stationary. Indeed,
we expected RT-RP duplicates to be evolving neutrally for exactly these reasons. The precise
combination of forces enabling the retention of duplicated genes in complex genomes leading to the
formation of gene families has been a subject of much study [3,55]. Several interesting studies have
focused on the fate of ribosomal protein duplicates in non-mammalian lineages. RP duplicate fate after
WGD events have been closely studied in yeasts and plants [56,57]. RP duplicates have been shown to
be retained to maintain gene dosage after WGD [57–60]. But these retention events are not expected to
affect the relative stoichiometry between RPs.
However, the primary mode of duplication observed in the present study is RNA-mediated,
small-scale duplications, which could result in severe stoichiometric imbalance. Additionally, it has been
implied that RP duplicates after WGD can be selected for defined functions like increasing levels of gene
expression and divergence of gene function [61]. But evidence for this is not readily apparent in
mammalian RT-RPs. Population genetics suggests that duplicates should be lost long before adaptive
forces can fix them in the population [62]. Many models have been forwarded that attempt to explain
this apparent paradox and provide scenarios within which duplicated genes will be retained at the levels
observed in many genomes (for an excellent review see [5]). Understanding the origin and basis of the
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widespread selective pressure acting on mammalian ribosomal protein retroduplicates requires an indepth study of current models to account for this phenomenon. Chapter 3 details the findings of this
study.

Chapter 3: Evaluation of Gene duplication models with duplication
mechanisms.
Based on our analysis detailed in chapter 2, we found more than 1000 young and old
retroduplicates that have been conserved over evolutionary time and a subset of those have also been
shown to have transcriptional signatures. We juxtapose these findings with known molecular
mechanisms and models of gene duplication. By performing this analysis, we hope to uncover a likely
rationale to explain these findings or enable us to propose a better model to account for this
phenomenon.

3.1 Mechanism of Gene Duplication
The first step in any gene family evolutionary process is the occurrence of DNA duplication and it
is known to arise randomly in individuals within a population. These duplicates then need to be fixed in
the population for continued persistence across subsequent generations. The persistence of these
duplicates are dependent on a variety of factors, which will be discussed in the next section.
There are four main molecular mechanisms through which DNA duplication occurs, 1) unequal
crossing over 2) duplicative (DNA) transposition, 3) retrotransposition, and 4) whole genome
duplication. Figure 8 below, adapted and edited from Zhang review paper [62], provides an overview of
all these gene duplication mechanisms.
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Figure 8 – Common Mechanisms of Gene Duplication. A) Unequal Crossing Over, B) DNA Transposition, C) Whole
Genome Duplication and D) Retrotransposition.

3.1.1 Unequal crossing over
Unequal crossing over occurs when two homologous sequences on different chromosomes
misalign during recombination. Depending on the position of crossing over, the duplicated region can
contain part of a gene, an entire gene, or several genes. In the latter two cases, introns, if present in the
original genes, will also be present in the duplicated genes. Crossing over in a bivalent carrying a
duplication in one of the two chromosomes may lead to different consequences; a couple of scenarios
are described below [63]. If the duplicated segment pairs with its homologous segment in the other
chromosome with complete disregard of flanking homologous segments, then the unequal crossing
results in an additional copy of the duplicate’s flanking DNA [63]. If the duplicated segments are present
in reverse order compared to the original segments or if duplication is present on the other arm in the
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same chromosome, then during crossing over, there is a possibility to form either dicentric or acentric
chromosomes. If the duplicated segments are found in a nonhomologous chromosome, crossing over
with this duplicated region will produce two interchange chromosomes [63,64]. Estimates from
Arabidopsis thaliana, Mus musculus, Rattus norvegicus, Homo sapiens, and Saccharomyces cerevisiae
put the number of tandemly arrayed duplicates between 10% and 20% of all genes, though the exact
meaning of ‘‘tandem’’ varies in each study [65–67].
3.1.2 DNA Transposition
Duplicative transposition of DNA sequences can be accomplished by 1 of 2 main pathways: nonallelic homologous recombination (NAHR) or non-homologous end joining (NHEJ; reviewed in [68]). The
difference in the 2 pathways is largely based on whether homologous sequences are used as a template
during double-strand break repair, and this difference can also be used to infer the mechanism by which
individual genes are duplicated (unequal crossing-over is a form of NAHR, albeit involving closely linked
sequences). Bailey et al. found an enrichment of transposable elements at the junctions of interchromosomally duplicated sequences in humans [69], a pattern also recently found in Drosophila
melanogaster [70]. Recombination between these non-allelic homologous sequences can result in
multiple rounds of duplication of the flanking sequences, due to pairing between the new paralogs [69].
Other studies in humans have also found multiple cases with no repetitive DNA or long stretches of
homologous sequence at duplication breakpoints, suggesting the action of NHEJ [71]. Due to the
relatively low proportion of duplicated sequences arranged in tandem in the human genome, it has
been proposed that duplicative transposition (of one mechanism or another) is the major mode of
duplication in humans [22].
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3.1.3 Whole Genome Duplication
Whole-genome duplication is a process whereby two or more genomes are brought together
into the same nucleus, usually by hybridization followed by chromosome doubling. This results in new
gene copies of every gene in a genome and all the flanking regulatory sequences. Though every gene is
duplicated, only 10–30% of all genes are maintained in the genome for very long periods [72,73]. The
type or function of genes maintained after polyploidization appears to differ from those duplicated by
smaller scale mechanisms. Most of the genes retained after whole-genome duplications exhibit dosage
effects (reviewed in [74,75]). Though an excess of duplicates in these categories have not necessarily
held up in studies of additional taxa (e.g., [56,76]), polyploidy events are likely to have had a large
impact on genome evolution and gene duplication.
3.1.3 Retrotransposition
Retrotransposition occurs by mobile genetic elements that copy themselves into other regions
of the genome, using RNA intermediates and reverse transcriptase. Primarily, retrotransposition occurs
when an mRNA is retrotranscribed to cDNA and then inserted into the genome. There are several
molecular features of retroposition: lack of introns and regulatory sequences of a gene, presence of a
poly-A sequence, and presence of flanking short direct repeats [77]. Because promoter and regulatory
sequences of a gene are not transcribed and hence not duplicated by retroposition, the resulting
duplicate often lacks necessary elements for transcription and thus immediately becomes a
pseudogene. Nevertheless, several retroposition-mediated duplicate genes are expressed, probably
because of the chance insertion of cDNA into a genomic location that is downstream of a promoter
sequence. Recent studies have found that retrogenes that are integrated near other coding regions or
even in introns of expressed coding sequences are much more likely to be expressed than those that are
integrated far from coding sequences [7].
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3.2 Models of Gene Duplication
3.2.1 Neofunctionalization
One of the more notable mechanisms for the preservation of a pair of gene duplicates is the
process of neofunctionalization whereby one copy acquires a beneficial mutation that results in a new
function. Models of neofunctionalization via gene duplication generally assume that new beneficial
functions are acquired at the expense of essential ancestral functions. The primary reasoning being that,
selectively advantageous mutations with no negative pleiotropic effects on wild-type fitness should have
had no barriers to fixation prior to duplication [78]. Under this reasoning, the temporary phase of
redundancy provided by gene duplication is thought to release one copy from prior selective
constraints; thereby enabling it to take on an adaptive feature [3]. A well-studied example of
neofunctionalization is GLUD2, a duplicate glutamate dehydrogenase gene in humans and apes, that is
important for glutamate detoxification after neuron firing, appears to have gained expression in the
brain and testes after human-Old World monkey split and it also shows signs of directional selection on
its protein sequence [5,79].
There are two most common neofunctionalization models namely, Dyhkhuizen–Hartl model and
Adaptation model. Dykhuizen–Hartl model for gene duplication proposes that none of the mutations at
the redundant locus are fixed by selection [5,80]. Instead, mutations accumulate due to drift and at
some later point in time there is a change in environment such that the new version of the duplicated
gene is advantageous to the organism. The important feature of this model is that none of the new
mutations at the redundant locus ever have a fitness advantage over another segregating allele before
they are fixed [81]. The Adaptation model posits that a new function occurs by the adaptive fixation of
mutations at one of the duplicated loci [82]. However, it is not clear if this model specifies whether the
first “illicit” mutation is fixed by selection or whether only subsequent mutations are [3,5].
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3.2.2 Subfunctionalization
The general opinion in the gene duplication literature is that mutations occur in the protein
coding regions on such a large time scale that most duplicates are lost or degenerated before the
occurrence of neo-functionalization [83]. This brings up an interesting question whether there are other
mechanisms at work that preserve gene duplicates for a long enough time to enable acquirement of
novel functions. One of the potential answers to this question can be provided by the outcome of subfunctionalization. It hypothesizes that after duplication, the function of an ancestral protein can get
partitioned between the duplicates, so that both copies are needed to perform the complete ancestral
function. To illustrate with probable scenarios, this may entail mutations in regulatory regions to
facilitate expression in multiple tissues. Another scenario could involve mutations in protein coding
regions that result in different active sites in each duplicate [84]. Additionally, this outcome doesn’t
require the action of selective forces; contrasting to most of the other models and outcomes. A classic
example for this outcome is the engrailed gene in zebrafish. Engrailed-1 and Engrailed-1b are pair of
transcription factor genes in zebrafish generated by a chromosomal segmental duplication (discussed in
[84]). Sub-functionalization can be observed as engrailed-1 is expressed in the pectoral appendage bud,
whereas engrailed-1b is expressed in a specific set of neurons in the hindbrain/spinal cord. This was
enabled by degenerative mutations found in the regulatory regions of these paralogs.
There are several models that fall under sub-functionalization, namely, gene sharing,
specialization, Escape from Adaptive Conflict (EAC) and the most famous and highly discussed
Duplication-degeneration-complementation (DDC) model. Gene sharing model posits that an ancestral
protein which perform multiple distinct functions can undergo duplication and subsequently its
functions can be partitioned among the duplicates and further improved as explained by models like
Specialization and EAC [85–87]. Specialization model proposed by Hughes et al., suggest that if the

28

original gene was performing two functions that could not be independently improved, then after
duplication, each gene copy can be driven by positive selection to specialize — that is, to improve one of
the two functions [87]. The widely accepted model that has defined sub-functionalization is the DDC
model. According to the DDC model, degenerative mutations can occur neutrally in both copies as long
at the duplicates as a pair retain all ancestral functions [84]. The aforementioned example for the
engrailed gene in zebrafish fits this model. After duplication, purifying selection is expected in both
genes, but its intensity might be relaxed compared with the pre-duplication phase. At the end of the
fate determination phase, the original function will be partitioned by the two genes in terms of
expression or protein function in a neutral manner without the involvement of positive selection
[84,88].
3.2.3 Gene conservation
Ohno addressed this outcome with the reasoning that maintenance of a gene duplicate was to
simply increase the number of genes coding for a protein. In this case, both loci maintain the original
functions of the gene, and hence is known as ‘‘gene conservation’’[62]. Multiple authors have also
recently proposed that this is a major force in duplicate gene retention [88–90]. A pertinent example for
gene conservation was studied by Perry et al.,[91] discussing the variation in the number of duplicates of
the salivary amylase gene (AMY1) among humans. They found that human populations that consume
starch-rich diets had on average more copies of AMY1 per individual and that this translated into higher
protein levels and enhanced ability to break down starches.
There are two proposed models in this category to explain why these duplicates would maintain
the original functions, namely Redundancy model and Dosage model. Redundancy model specifies that a
second gene could provide functional redundancy if the original locus was disabled by mutation and the
Dosage model posits that there is an advantage to producing more of a gene. While it is certainly true
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that increased levels of protein production can be achieved by increasing gene expression, duplicating a
gene can potentially have an equivalent effect [3,92].
3.2.4 Pseudogenization
It is generally not advantageous for species to carry two identical genes. Duplication of a gene
produces functional redundancy. Pseudogenization, the process by which a functional gene becomes a
pseudogene, usually occurs in the first few million years after duplication if the duplicated gene is not
under any selection [93]. The two major forces of pseudogenization are mutation and deletion, where
changes in pseudogenization occur through promoter mutation, nonsense mutation or missense
mutation in coding region, or loss of exon splicing junction. Mutations that disrupt structure and
function of one of the two duplicate genes are not deleterious and are not removed by selection.
Gradually, the copy of the gene that accumulates mutations becomes a pseudogene, which is either
unexpressed or non-functional [62]. After a long time, pseudogenes will either be deleted from the
genome or become so diverged from the source genes such that they are no longer identifiable. Humans
and mice have similar number of members of the olfactory receptor gene family (∼1000 genes) but the
proportion of pseudogenes is >60% in humans and only 20% in mice. This may be due to reduced use of
olfaction since the origin of hominoids, which can be compensated by other sensory mechanisms, such
as better vision [63]. Occasionally, pseudogenes may also serve some functions. In chicken, there is only
one functional gene (VH1) encoding the heavy chain variable region of immunoglobulins, and
immunoglobulin diversity is generated by gene conversion of the VH1 gene by many duplicated variable
region pseudogenes that occur on its 5’ end [94].
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3.3 Reconciling current duplication models with observed number of conserved RPG
duplicates from our study
Population genetics suggests that duplicates should be lost long before adaptive forces can fix
them in the population [62,89,95]. To be successful in the long term, a duplicate gene must first drift
toward fixation, and then, once it has risen to a high frequency, the selective forces for its maintenance
must be sufficiently large to prevent its subsequent loss by degenerative mutation [78]. Many models
have been forwarded that attempt to explain this apparent paradox and provide scenarios within which
duplicated genes will be retained at the levels observed in many genomes (for an excellent review see
[5]). In an attempt to understand the origin of the widespread selective pressure we observe on
mammalian ribosomal protein retroduplicates, we focus this discussion on the ability of current models
to account for this phenomenon.
3.3.1 Neofunctionalization
Gene duplication models for neofunctionalization, namely, the Dyhkhuizen-Hartl model, the
Adaptation model, and the Adaptive Radiation model, predict that the rate of evolution after gene
duplication will be accelerated in the duplicated copy and constrained in the original gene [5,62,88].
However, these models fail to account for thousands of ribosomal retrogenes in our dataset which
demonstrates that rather than experiencing neutral selection, the new copy is under stringent purifying
selection. Moreover, while some extra-ribosomal functions for divergent RP duplicates has been
observed, these events appear to be very rare [96]. Therefore, neofunctionalization models appear
unlikely to account for the very large number of conserved ribosomal protein gene retroduplicates in
mammalian genomes.
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3.3.2 Subfunctionalization
Subfunctionalization, and its most cited model, DDC does appear to account for the retention of
a number of gene duplicates [5,84]. DDC postulates that the genetic drift and accumulation of mutations
will cause the loss of specific subfunctions from each copy of the duplicated genes. Once one copy has
lost an essential function, selection on that function in the other duplicate will be reasserted. Eventually
the two copies preserve largely non-overlapping complementary functions and both must be
maintained by selection [84]. This division of function can result from changes in the regulatory regions
or the coding regions of duplicated genes, and is most often envisioned as a driving force for the
divergence of gene expression (for example see [60]).
However, DDC seems an improbable model for retention of the ribosomal protein retrogenes
due to the fact that rather than appearing to drift, the coding regions of these duplicates are under
strong purifying selective pressure. Large numbers of degenerative mutations in the coding regions are
not observed until after pseudogenization. Also, because RT-RP duplicates do not carry any regulatory
information, the most likely scenario for DDC, the evolution of complementary regulatory regions is
unlikely. In addition, EST signatures retrieved from our pipeline and a review of existing literature [97]
suggests that retroduplicates typically have a much narrower expression profile compared to the
ubiquitous expression patterns of their source genes. The source genes never seem to lose ubiquitous
expression, as would be expected under DDC. Hence, division of function in such a manner seems
improbable for ubiquitously expressed ribosomal source genes. Other sub-functionalization models like
EAC [98] and specialization [99] require neutral selection on the duplicate copy [88] and are not
consistent with the purifying selective pressure we observe.

32

3.3.3 Gene conservation
Gene conservation is another outcome that can be used to explain the retention of retrogenes.
The primary gene conservation model that has been employed to explain gene retention is the dosage
model, which posits that gene duplicates are retained in order to produce more of the same gene
product [3,100]. In comparison, the dosage compensation model states that the gene duplicates can
compensate for the activity of the source gene [62]. The RP genes are under strict transcriptional
regulatory control to maintain equimolar ratio of ribosomal constituents [26,101,102], and changes in
ribosomal protein levels, including overexpression, are often highly deleterious [100,103]. This point is
confirmed by DeSmet et al., 2013 paper [104] as they suggest that retention of small scale duplications
(SSDs) will result in the stoichiometric imbalance among protein complexes and that the dosage balance
hypothesis would work for a WGD as relative ratios among subunits can be flawlessly maintained, which
would not be the case with SSDs. Similar conclusions were drawn for SSDs, suggesting that they would
be selected against in a highly connected protein network [105]. This suggests that retroduplications
that alter gene dosage would be selected against, not favored.
Another very important piece of evidence that argues strongly against the retention of RT-RP
duplicates by dosage is the study conducted by Kittler et al., and Gilsdorf et al.[106,107]. In this study,
34 ribosomal retrogenes (highly conserved old, new, intact and pseudogenized candidates) were
knocked-down with no detectable phenotypic defects. However, knock-down of each of 70 source RP
genes had drastic phenotypic defects on the cells, with no evidence of retrogenes compensating for the
loss of source gene products (data obtained and analyzed from[107]).

3.4 Examples of Gene Duplicates in light of Mechanisms and Models
As there are 4 different mechanisms by which gene duplication occurs and many different
models to explain the retention of gene duplicates, it was important to conduct a systematic study to
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compare each model and mechanism uniquely to find whether any combination successfully explain the
retention of highly conserved retroduplicates (see Figure 9 and Table 2- for convenience, the references
used for the figure and the table 2 are listed separately in supplementary table 2).

* Models that have no superscripted reference belong to ref 17 and ref 18 in supplementary table 2
Figure 9 – Mechanisms in Light of Gene Duplication Models. The four columns in this figure represent the
mechanisms by which gene duplication takes place, first 3 columns representing DNA-mediated duplication
mechanisms and the last one represents RNA-mediated ones. The rows in this table represent all the standard
gene duplications models to explain certain gene duplicate fates. In green, are listed all the known examples when
a particular model is tested against the mechanism (For reading convenience, all references for this table are
provided in the Appendix 2). We have also categorized probable events (blue text), plausible but unlikely events
(orange text) and improbable events (red text). Some of these categories don’t have annotated examples, but can
be confidently placed in a category due to findings in literature.

In Figure 9, boxes with green text represent “Known Examples”, when the model was tested
against a mechanism. For example, a particularly interesting instance of gene conservation has been
uncovered in yeast by Conant and Wolfe [108], who hypothesized that retention of specific glycolytic
genes after WGD in yeast has caused an increased glycolytic flux that gave post-WGD yeast species a
growth advantage by increasing their glucose fermentation speed. Hence, this example would mark the
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explanation of WGD duplication mechanism by gene conservation model, specifically the dosagebalance model. All the other examples (boxes with green text) were reasoned in the same manner for
Figure 9 and the expanded table with more examples and scenarios of retention can be seen in Table 2
below. Published examples were used wherever possible and if examples were not possible, we try to
reason the possibility of a mechanism to fit a model based on findings in literature. Boxes with blue text
represent “Probable” cases and boxes with orange text represent all the “Plausible but unlikely” cases
for a particular mechanism and duplication outcome. Boxes with red text denote “Improbable” cases. In
this figure, we consider all the models for which we found atleast one known example. As seen in this
table, based on current findings, all the mechanisms except for retrotransposition have been
represented by more than one gene duplication model. A clear distinction can be observed when it
comes to retrotransposition as none of the models within any outcomes, apart from
neofunctionalization, can explain retention of RNA-mediated gene duplicates. The known examples for
retrotransposed genes that can be explained by neofunctionalization models required the gene
duplicate to be free of any selective pressure to eventually acquire beneficial mutations. We do not
observe freely evolving duplicates as our ribosomal protein gene duplicates are clearly under strong
selective pressure and their retention cannot be explained by any of the neofunctionalization models.
Thus, after our detailed study of gene duplication mechanisms and models, the highly conserved
retrotransposed gene duplicates that we discovered do not seem to fit under any discrete category.
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Table 2: Mechanisms in Light of Gene Duplication Models. Expanded version of Figure 9.

GENE DUPLICATION MECHANISMS
DNA-mediated
MODELS
Redundancy
(Hahn 2009; Gu et al.,
2003)
The loss of function in
one copy can be
compensated by the
other copy.
Dosage
(Hahn 2009)
There is an advantage
to producing more of a
gene product.
Dosage balance effect
(Papp et al., 2003)
Each gene’s expression
is expected to remain
in the same
stoichiometric
relationship with all of
its interacting
partners.
DDC
(Force et al., 1999)
Partition of nonoverlapping functions
between gene
duplicates through
degenerative
mutations in the
regulatory region.
Gene sharing
(Piatigorsky 2007)
Proteins with multiple
distinct functions.

Neofunctionalization

○ - known example

RNA-mediated

Whole Genome
Duplications
○
Majority of duplicates that
arose through WGD in Yeast
can be explained by this
model (DeLuna et al., 2008).

Unequal crossing-over
(tandem)
○○
Highly probable due to
tight linkage.

Duplicative (DNA)
transposition
○○
Possible due to genes or
parts of genes duplicated
by this mechanism.

Retrotransposition

×
Increase in gene product is
not limited to specific set of
genes, but rather is
universal.

○
Increase in AMY1 copy
number correlates to
human population that
consume starch rich
diets (Perry et al. 2007)
○○
Highly probable in
genes with strong
linkage.

○○
No examples were found
to show this yet.
Plausible if regulatory
regions are also copied,
otherwise unlikely.
○○
Highly probable in genes
with strong linkage.

×
No examples were found
to show this yet.

×
Having separate
regulatory regions is
impossible in this
duplication mechanism.

○○
No examples were found
to show this yet. This
scenario is probable
when the duplication
also involves copying of
the regulatory region.

×
No known examples were
found. Low to no
probability due to lack of
native regulatory region.

○○
No examples found, but
it could potentially
work.

○○
No examples found, but
it could potentially work.

×
No known examples were
found. Low to no
probability due to lack of
native regulatory region.

○
ECP and EDN genes
were produced by
tandem gene
duplication from an
EDN-like ancestral gene
after divergence of Old
world and New world
monkeys, but before
separation of
hominoids and Old
world monkeys (Zhang
et al., 1998).
x - improbable

○
Human immunoglobulin
Vx genes (Zimmer et al.,
1990).

○
A neutrally evolving
retrocopy RBMXL1 (RNA
binding motif) gene is
found to be intact in six
old world primates
(Marques et al., 2005)
×
Under purifying selection,
as seen in in RT-RPs, this
scenario does not apply.

○
Metabolic genes appeared
to be more retained than
other genes after recent
WGD in yeasts (Gou et
al.,2009). Eg: Retention of
glycolytic gene duplicates in
yeast results in increased
glycolytic flux (Conant
2007).
○
ZAG1 and ZMM2 in maize
originated via
allotetraploidization event
between two closely related
grasses about 11 mya.
(Force et al., 1999)

○
Gal1 and Gal3 are WGD
derived duplicates from a
bifunctional ancestral
protein in yeast. (Hittinger
et al.,2007)
○
Myb gene in vertebrates
arose through whole
genome duplication and
subsequently
neofunctionalized (Davidson
et al., 2005).

○○ - probable
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×
Hard to get identical
functions by RT.

×
Almost impossible to
maintain balance via retro
transposition.

3.5 Retention of RT-RPs cannot be readily explained by current models
As discussed in the previous sections, it is clear that existing models do not adequately (if at all)
account for the retention of retroduplicated genes in RPG gene families. Due to the fact that
retroduplicates like RT-RPs (discussed in chapter 2) are abundant, highly conserved, lack source gene
regulatory regions, and because changes in ribosomal gene dosage are strongly selected against, the
retention of the RT-RP duplicates is not readily explained using current models of Ohno’s three
trajectories of dosage, subfunctionalization, and neofunctionalization [3]. Additionally, we have also
shown that in mammalian genomes, RNA duplications comprise half of all conserved duplicated genes.
Thus, any set of models that hopes to explain the bulk of duplication events contributing to mammalian
genome evolution must account for RNA-based duplicates. All the models that are found in the
literature tend to explain the terminal retention of duplicates and the potential consequence of the
duplicate once fixed in the population. However, it is very important to describe the forces that could
influence the early evolutionary trajectory of a large percentage of all gene duplication events. Based on
the above observations, it is clear that there is a need to introduce a new model that can explain
conserved retroduplicated gene duplicates that persist in the genome and don’t seem to
neofunctionalize, subfunctionalize or be retained for gene dosage, and can become inactivated even
after millions of years of purifying selection.

Chapter 4: Introducing and Testing the DPI Model to Explain Retention of
Previously Unaccounted Gene Duplicates
4.1 DPI, a model to explain the effect of Dominant-Negative selection on gene family
evolution
One factor not fully explored in most existing models for the retention of duplicated genes is the
potential for dominant-negative effects of missense mutations on cellular processes. In an attempt to
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explain the retention of large numbers of duplicates that we discovered earlier as studied in Chapter 2,
we devised a model that we coined as Duplication, Purification, and Inactivation (DPI) model. This model
posits that gene duplicates are retained in the genome not because they contribute to the fitness of the
organism, but rather because missense mutations in these genes are not tolerated due to dominant
negative effects of missense alleles. Mutant proteins can act in a dominant-negative fashion in a wide
variety of ways [76,109,110], and this model could account for the strong purifying selective pressure
we observe on duplicated genes. The acquisition of dominant-negative mutations in duplicates may
represent a threat to the viability of an organism via expression alone (see Figure 10 for an illustration).
Thus, these gene copies will remain under purifying selection until they are inactivated
(pseudogenization or transcriptional silencing) or acquire a fate determining mutation. We suggest that
dominant negative phenotypes may exert an immediate and strong purifying selective pressure upon
any duplicated gene, with this pressure directly proportional to the potential for the gene product to act
in a dominant negative fashion [76] (Figure 10).
Another salient feature of the DPI model is that a dominant-negative mechanism does not
require complementation, neofunctionalization, subfunctionalization, ubiquitous expression, or a
selective advantage for the new copy. In a recent study of flowering plants, De Smet et al., postulate a
very similar idea that dominant negative model constrains genes to be maintained as single copies to
avoid non-specific interactions [104]. Strongly conserved multiprotein complexes like the ribosome are
most commonly observed to exhibit dominant negative phenotypes, but dominant negative phenotypes
are not restricted to such multi-protein complexes, in fact, they are widespread [110].
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Figure 10: Illustration of the Duplication, Purification and Inactivation (DPI) Model: A model for retention of
duplicate genes through purifying selective pressure against dominant negative alleles. The model states that
gene duplicates are retained in the genome not because they contribute to the fitness of the organism, but rather
because missense mutations in these genes are not tolerated due to dominant negative effects of missense alleles.
In the top panel, a wild-type ribosomal protein (WT RP) and its epitopes (orange and blue rectangle) are interacting
with the eukaryotic ribosome represented in blue and yellow, with mRNA represented as a single-strand in dark
blue. When ribosomal proteins are all present in equal stoichiometric amounts, normal translational activity as
well as normal functionality is observed. At this point, the ribosomal protein gene duplicate (RP-DUP) would not
interfere if it is constrained by strong selective pressure. In the bottom panel, along with the WT RP, a dominantnegative version of a ribosomal protein gene duplicate (DN RP-DUP) with a missense mutated domain in the
epitope (magenta circle) is shown to be interacting with the ribosome. DPI model claims that when the WT RP
interacts with the ribosome, normal translational activity and function would be observed, while interaction of the
DN RP-DUP with the ribosome results in deficient translational activity leading to absence of ribosome function.
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Because selection against dominant negative alleles acts immediately upon newly duplicated genes, and
serves to maintain gene products in a very restricted portion of protein conformational space, it likely
facilitates the retention of duplicates by many of the models described above by increasing the half-life
of functional alleles in the population and the exploration of the small local region of allowable variation
in protein conformation. Liberles and coworkers have proposed similar models in the context of
negative pleiotropy [105,111–113], and have reached parallel conclusions on the impact of these
bottlenecks in sequence space during evolution. To gain support for these models of gene family
evolution, it will be important to functionally test the hypothesis of these models in experimentally
tractable systems.

4.2 In silico & in vitro predictions and tests for the DPI Model
The DPI model for the retention of duplicate genes by dominant negative forces makes a number of
explicit, testable in vitro and in silico predictions.
4.2.1 In silico predictions
The bioinformatics investments we have made in lab over the past few years have enabled us to
be in an excellent position to test important in silico predictions for the DPI model. As seen in Chapter 2,
we built a novel pipeline to both characterize gene family members and trace their evolutionary
trajectory. We seek to expand out of ribosomal families and show the universal applicability of the DPI
model in other gene families. We targeted gene families known to be susceptible to dominant negative
effects and tested the following predictions to further support the DPI model:
1) Any gene that can act as a dominant-negative (DN) will be part of a relatively smaller gene family than
its non-DN counterparts.
2) Purifying selection will be stronger on gene families with known dominant-negative genes; and,
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3) Purifying selection will be enforced regardless of the number of copies of dominant-negative genes in
a given gene family.
In order to address these predictions of the DPI model, we have created a pipeline as seen in Figure 11
below.

Figure 11: In Silico Pipeline to test DPI predictions. Protein sequence annotations for all gene families were
collected using the ENSEMBL62 database. These gene families were annotated as dominant-negative (DN) or non
dominant-negative (non DN) families using the annotations from the Online Mendelian Inheritance in Man (OMIM)
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database. Guilt-by-association approach was utilized to pick out DN gene families based on presence of atleast one
annotated DN member. These genes were cross-referenced to Pseudopipe data to capture all the putative gene
duplicates. We then utilized our in-house pipeline steps of hierarchical clustering by local synteny to build our gene
family trees after filtering false-positives and redundant entries. Final gene family analyses were separated in 2
steps: 1) Analysis of DN and non-DN Gene Family sizes, and; 2) calculating the selective pressures on all DN and
non-DN gene families using PAML branch-wise method.

4.2.2 In vitro predictions
A unique feature about the DPI model is that some of the key predictions that it makes can be
tested directly in vitro. This feature seems to be missing in most of the contemporary gene duplication
models, which renders it to be more theoretical in nature. In vitro predictions that we will test for the
DPI model are:
1) There will be no fitness penalty incurred through inactivation of the conserved duplicate gene copy,
and
2) Induction of the duplicate gene can rescue the function of the source gene, however missense
mutations in the duplicate copy will have a high probability of exerting dominant negative effect.
We test these predictions for candidate ribosomal protein gene duplicates identified through
our previous studies. We designed a series of experiments that allow us to rigorously test these gene
duplicates using precise genetic modifications of HEK293T cells. For the first prediction, we employed
the use of the CRISPR/Cas9n system to knockout source and duplicate genes independently (Pipeline A
on the left in Figure 12). To test the second prediction, we designed a complementation-rescue system
with which we induce the expression of the duplicate gene using the PiggyBac cumate induction system
and knockout the source genes using the aforementioned CRISPR/Cas9n system (Pipeline B on the right
in Figure 12). See Materials and Methods section for more information on the protocol steps used in
Figure 12.
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Figure 12: In Vitro Pipelines to test DPI predictions. A) Schematic of the CRISPR-CAS9 pipeline to knockout source
and duplicate ribosomal protein genes. B) Schematic of the Complementation Pipeline for Ribosomal Protein
Candidates RPS15 and RPS26. See Materials and Methods for more information on the experimental setup and
details.

4.3 Testing Key In Silico Predictions of the DPI Model
4.3.1 Comparative Analyses of DN and Non-DN Gene Family Sizes
The first in-silico test for the DPI model involved testing whether gene families that can act in a
dominant-negative (DN) fashion would maintain low gene family member counts compared to non-DN
gene families due to the constraints on DN genes to be maintained as single copies to avoid any and all
non-specific interactions.
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The member count distributions of both DN (n=493) and Non-DN gene families (n=11945) were
compared and their log transformed distributions are shown in Figure 13 B and C. We clearly observe
that DN-gene families have fewer members in the family compared to non-DN gene families. The
moments data for DN and non-DN families is also shown in Figure 13A. We found a statistically
significant difference between the two datasets and also found that the distribution of DN gene families
lies below that of Non-DN gene families (one sided Kolmogrov-Smirnov (KS) p-value < 0.01), confirming
the smaller gene family size for DN gene families (Figure 13D).
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Figure 13: DN and non-DN gene family analyses. Gene Families that can act in a dominant-negative (DN) fashion
have smaller family sizes than non-DN gene families. A) In the top panel, moments data is shown for DN and nonDN families. B and C) In the middle panel, DN and non-DN families are shown on X-axis respectively and logtransformed values for gene members in each family on Y-axis. D) Results from one and two-sided non-parametric
Kolmogrov-Smirnov test for DN and non-DN families are shown.

4.3.2 Selective Pressure Analyses of DN and Non-DN Gene Families
Since we observe relatively smaller family sizes for genes that are associated with DN traits, we
now wanted to take a closer look at the selective pressure constraints acting on DN and non-DN genes.
For our second in silico test of the DPI model, we calculated Ka/Ks ratios for all gene families in DN
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(n=472) and Non-DN gene family datasets (n=9100) using CODEML program in PAML (see chapter 2)
(Figure 14A). For the DN gene families, we observe a mean dN/dS value of 0.12 (95% CI 0.0128, 0.016)
and 0.18 (95% CI 0.018, 0.019) for Non-DN gene families. We also observed that there was significant
difference between these two distributions (bootstrapped p-values <0.01 and n=1000). To test whether
this selective constraint is an artifact of family member size, we binned distributions of DN gene families
based on their member sizes (Figure 14B). We statistically confirm that member sizes do not influence
change in Ka/Ks ratios (post-hoc HSD test pair-wise pvalues <0.01).

Figure 14: Selective Pressures on DN and non-DN gene families. A) Box and Whisker plots depicting branch-wise
Ka/Ks ratios calculated for DN and non-DN families using the codeml program in PAML. B) Box and whisker plots
show selective pressures calculated for all DN gene families binned based on the number of members in each gene
family.
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4.4 Testing Key In Vitro Predictions of the DPI Model
4.4.1 Ribosomal protein gene candidates and CRISPR-Cas9n sgRNA designs
To find appropriate ribosomal protein gene candidates to test the DPI model, we examined the
source and duplicate gene dataset we had generated previously [114]. By mining our duplicate gene list
based on selective pressure and expression data, we selected RPS15 and RPS26 source genes (as
annotated by ENSEMBL 62) and their respective retrotransposed gene duplicates as candidates. RPS15
gene duplicate is located on the negative strand of human chromosome 2:172373783-172374226 and
RPS26 gene duplicate is located on the negative strand of human chromosome 4:114135205114135549. Our selection of the candidate genes were also based on their expression, integral function
in the ribosome and the possibility of designing unique CRISPR gRNA sequences. Structural locations in
the 80S ribosome and their amino acid sequence alignments for source and duplicate RPS15 and RPS26
can be observed in Figure 15. RPS15 and RPS26 source sequences from here on will always be depicted
in light green and light purple respectively and their duplicate genes in dark green and dark purple
respectively.
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Figure 15: Ribosomal protein gene candidates to test the DPI model A) Schematic showing the locations of human
ribosomal protein genes RPS15 and RPS26 in the global map of the 80S human ribosome. This is a view looking
down the 80S ribosome from the 40S head/60S central protuberance. For the 60S subunit, protein is shown in dark
blue and rRNA in slate blue. For the 40S subunit, protein is shown in yellow and rRNA is in pale yellow. The black
arrow marks the path of the mRNA and the grey structure represents the tRNA. RPS15 and RPS26 source genes are
shown in Purple and green respectively. B) Protein sequence alignment of RPS15 (top panel) and RPS26 (bottom
panel) source and duplicate amino acid sequences. The differences are highlighted in yellow. RPS15 source gene
sequence is represented in light green and the RPS15 duplicate gene in dark green. RPS26 source gene sequence is
represented in light purple and the RPS15 duplicate gene in dark purple.

Both the proteins are found in the 40S subunit and are located on the surface of the ribosome
near the A-site and have been implicated in the mRNA binding. They are also involved in the 40S
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maturation and seem to be a determinant of pre-ribosomal export from the nucleus (See Figure 15A).
For our candidates, we wanted to confirm that the EST tags that were associated with them were
reliable. In order to conduct an effective functional test for the DPI model, it is important that the gene
duplicates are expressed in the cells of interest. Thus, we used qRT-PCR to validate expression of the
source and duplicate genes we had selected. Their transcript-level expression in our experimental cell
line HEK293T is illustrated in Figure 16. The source genes have 1.5-2 fold more mRNA expression than
duplicate genes.

Figure 16: qRT-PCR gene expression testing for ribosomal source and duplicate protein gene candidates.
Representative genes showing gene expression in HEK293T cells. Messenger RNA levels for GAPDH, RPS15 source
and duplicate gene and RPS26 source and duplicate gene are shown in the graph. Expression values for all
probesets were log2 transformed. Housekeeping gene GAPDH is represented in grey, RPS15 source gene in light
green, RPS15 duplicate gene in dark green and RPS26 source gene sequence in light purple and RPS26 duplicate
gene in dark purple respectively.

4.4.2 Efficient CRISPR-Cas9 mediated gene targeted knockouts of source and duplicate genes of human
RPS15 and RPS26 ribosomal proteins
While previous studies have shown siRNA knockdowns of RPS15 and RPS26 source genes lead to
defects in 40S production, ribosome biogenesis defects and reduced levels of 18S rRNA [106,115–117],
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we wanted to confirm the phenotypic effects on our candidate mammalian cells. To this end, we
employed the widely used CRISPR-Cas9 system to precisely knock-out either the parental or duplicate
ribosomal genes and assess the impact on cellular fitness. Due to high similarity between the parental
and duplicate genes, we used the double-nickase CRISPR system which relies on two specific targeting
events to delete the region of interest [118]. Using this system we avoid off-target effects and ensure
targeting of the correct gene copy. In this system, a pair of plasmids each encoding a Cas9 (D10A)
nickase mutant (Cas9n) are directed to distinct, genomic loci by a target-specific guide RNA. Each
Cas9n/sgRNA complex creates one nick in the DNA strand that is complementary to the guide RNA
[118]. The double nick created by the pair of Cas9n/sgRNA complexes mimics a DSB and results in end
resection and non-homologous end joining of the DNA fragments. Thus, the use of paired-guide RNAs
allows for increased specificity of Cas9-mediated gene editing, while maintaining a high level of
efficiency [118,119].
For RPS15 and RPS26 source genes, we used a pair of CRISPR guide RNAs that targeted the
exon1 and intron2 junction, hence avoiding any off-targeting in the intronless retroduplicate gene
candidates. For the duplicate gene candidates, we targeted the 5’ UTR region and exon 1 regions as the
UTRs were unique for the duplicate genes and hence off-targeting of source genes could be avoided.
Another salient feature of this system is that the region of the gene gets knocked out only if both the
guides are identified by the Cas9n mutant protein and hence helping us avoid any false-positive
knockouts. RPS15 and RPS26 source and duplicate CRISPR gRNA targeting regions and guide design
strategy can be seen in Figure 17 and all the guides used for the knockouts can be seen in Table S3. The
stepwise experimental strategy was previously presented in Figure 12A.

50

Figure 17: Representative sequences of RPS15 and RPS26 source and duplicate locus targeted by the Cas9n for
CRISPR knockouts. RPS15 and RPS26 source and duplicate gene sgRNA target sites are indicated in blue and
Protospacer adjacent motif (PAMs) are underlined in red respectively. Exon-Intron junctions were targeted for
source genes and UTR-Exon region were targeted for duplicate genes. See Table S3 for all the sgRNA sequences
that were used. Colored bars on the left depict the candidate for which the sgRNA designs were made.

4.4.3 CRISPR/Cas9 Gene Knockouts of ribosomal protein source genes and their gene duplicates
4.4.3.1 Cell Line Selection
The DPI model predicts that many stabilized RT-duplicates will be dispensable for the organism,
but when the source genes are knocked-out, it will exert dominant negative effects on the cell. The
shared phenotypes of ribosomal mutations include reduced protein synthesis, reduced proliferation
rate, impaired ability to compete with wild-type cells and lethality, all of which can be readily assayed in
tissue culture. Ribosomal protein synthesis is universally required for all cells, but the most stringent
requirement occurs in rapidly dividing cells, such as HEK293T cells. There are other features that make
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HEK293T cells an ideal choice, such as they are amenable to transfections, highly efficient & faithful in
translation etc.

4.4.3.2 CRISPR-Cas9 knockouts of gene candidates
In order to confirm the cellular growth defects that knocking out a ribosomal protein source
gene or its respective duplicate gene would cause, we used the double-nickase CRISPR-Cas9 system
protocol as previously mentioned [118,119]. After designing and cloning appropriate gRNA sequences
into the CRISPR plasmid, these plasmids were transfected into HEK293T cells and kept under antibiotic
selection. CRISPR knockouts of the source ribosomal protein genes RPS15 and RPS26 causes HEK293T
cells to crenate and lose adherence suggesting cell death and reduced cell viability in comparison to
Empty vector HEK293T cells (Figure 18). Although some cell death was observed at 24 hours posttransfection, it was most evident at 72 hours-post transfection.
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Figure 18: CRISPR CAS9 aided knockouts of Source RPS15 and RPS26 genes exhibit drastic phenotypic defects
while knockouts of duplicate genes do not affect the cell phenotype. A) Bar graph depicting crystal violet
absorbance values for wildtype HEK293T cells along with HEK293Tcells that were transfected with CRISPR sgRNA
guides to knockout RPS15 and RPS26 riboprotein source and duplicate genes. RPS15 source gene is represented in
light green bar and RPS15 duplicate gene in dark green. RPS26 source gene sequence is represented in light purple
and the RPS15 duplicate gene in dark purple. Values are means of ±SD (n=3). ** P-value < 0.01. B) Representative
microscopy images of the targeted cells are depicted below the bar graphs. See Materials and Methods for more
information on cell culture, CRISPR designs and transfection methods.

CRISPR knockouts of RPS15 and RPS26 duplicate ribosomal protein genes showed no signs of
crenation or loss of adherence. The cell viability and phenotype was comparable to empty vector & wildtype HEK293T cells. These source and duplicate gene knockout results were further confirmed with
photomicrograph images at day 3 (Figure 18 and S8) along with quantitative measurements of HEK293T
cell growth using the crystal violet staining for indirect measurement of cell viability (Figure 18).
We also confirmed that the CRISPR deletions we intended were being accurately created in the
cells by using the Surveyor Nuclease assays that cleaves DNA with high specificity at sites with basesubstitution mismatches (data not shown). Additionally, we also clonally isolated the source and
duplicate gene knockout cells that had survived after the knockouts were pursued, by isolating single
cells through Fluorescent-activated cell sorting (FACS). Once the single cells expanded into colonies, we
extracted DNA, performed a round of PCR to amplify the source and duplicate gene sequence
respectively and then pursued DNA sequencing analyses to analyze the candidate DNA sequences of the
cells. On performing sequence alignments between the source gene PCR product and respective source
gene (Figure S5), we show these cells that have survived selection did not have alterations in their
coding sequences, and thus were escapers that were not edited or only received one out of the two
CRISPR gRNA pairs. On performing sequence alignments between the duplicate gene PCR product and
duplicate gene, we show that the cells were transfected and were in fact edited accurately with sgRNAs
also present. This confirms that their knockout did not affect cell viability in this case.
Interestingly, we found all the above data to be concurrent with a major study pursued at the
Max Planck Institute (Dresden, Germany) where similar results were observed for a much larger set of
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source and duplicate genes, albeit the data was collected through knockdowns, instead of knockout
studies. In this study 34 ribosomal retrogenes (highly conserved old, new, intact and pseudogenized
candidates) were knocked-down with no detectable phenotypic defects. However, knock-down of each
of 70 parental RP genes had drastic phenotypic effects on the cells, with no evidence of retrogenes
compensating for the loss of parental gene products (data obtained and analyzed from [106,107]).
4.4.4 Complementation Rescue of the source RP gene function by its gene duplicate
Having shown that duplicate gene knockouts do not exhibit the growth and viability defects
observed for parental gene knockout, we assessed whether over-expression (induction) of the duplicate
gene could compensate for the loss of parental gene function. As the dominant negative mechanism of
the DPI model requires that duplicate genes compete for function in the ribosome, the duplicate gene
should be able to at least partially compensate for loss of the parental gene. The severe defects seen in
parental gene knockouts indicate that the endogenous levels of duplicate genes are not sufficient for
compensation. Hence, we overexpress (induce) the duplicate genes in parental knockouts to assess their
ability to rescue the source function in the ribosome.
The genetic complementation-rescue system we have developed leverages a dual hygromycinpuromycin antibiotic selection method (See Materials and Methods for more details) to select for cells
containing both the CRISPR-Cas9 knockout (puromycin) as well as a cumate-inducible piggyback vector
(hygromycin) used to overexpress the gene of interest. The experiment is designed to address whether
the induction of the duplicate gene in cells that will undergo a CRISPR knockout of the respective source
gene, rescue the source gene depletion and hence keep the cells viable avoiding crenation and cell
death. The pipeline for this experimental setup was shown previously in Figure 12B. As a positive control
for this rescue experiment, we also induced the expression of the source genes’ coding sequences in
HEK293T cells.
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Figure 19 shows results of duplicate gene’s expression induced in cells where the source gene is
knocked out. There is a detectable level of rescue that is observed (see absorbance graphs in 19A and C
and cell images in 19 B and D) in the form of significantly lower amount of cell crenation and death
when compared to source gene knockouts with no rescue (see Figure 18). However, it is important to
note that the rate of rescue is slightly lesser compared to the positive control. This indicates that while
the duplicate gene is able to rescue the function of the source gene at some level, the conservative
amino acid differences between the source and the duplicate gene may preclude a full
complementation seen in the positive control.
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Figure 19: Induced expression of the duplicate gene can rescue source gene function, but at a fitness cost arising
due to missense mutations. A) Bar graph depicting crystal violet absorbance values for HEK293Tcells that were
induced with source and duplicate cDNA respectively, followed by CRISPR/Cas9 transfections to knockout
riboprotein source gene. Induced RPS15 source gene with source gene knockout (positive control) is represented
in light green bar with white diagonal lines followed by non-induced RPS15 source gene with source gene knockout
in light green. Induced RPS15 duplicate gene with source gene knockout is shown in the next bar colored in dark
green with white diagonal lines followed by non-induced RPS15 duplicate gene with source gene knockout in dark
green. Identical representation is shown for RPS26 source and duplicate gene in C. Values are means of ±SD (n=3).
** P-value < 0.01. B and D) Representative microscopy images of the targeted cells are depicted below the bar
graphs for RPS15 in B and RPS26 in D. See Materials and Methods for more information on cell culture, CRISPR
designs and transfection methods.
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The protein structures depicting the conservative amino acid changes are shown in Figure 20. As
observed in Figure 20, the amino acid substitutions (shown in red) for both RPS15 and RPS26 occur in
exposed regions and do not seem to interact directly with other ribosomal proteins, while the amino
acids do not change at all for regions that seem to be directly interacting with other ribosomal units. The
insertion of 3 AA for the RPS15 duplicate protein (Figure 20A) is seen to be occurring in

Figure 20: RPS15 and RPS26 duplicate protein missense mutation illustrations. A) RPS15 duplicate protein shown
in green with the insertion of 3 AA pointed out in red. The right panel depicts the position of the mutational region
with respect to the ribosome. B) RPS26 duplicate protein shown in purple with the subsitituion of 3 AA at different
locations pointed out with red balls. The right panel depicts the position of the mutational region with respect to
the ribosome.

an exposed loop that does not interact with any other unit of the ribosome. Similarly, substitutions in
the RPS26 duplicate protein (seen in Figure 20B) are also extremely conservative in terms of amino acid
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size, charge and hydrophobicity. All these factors suggest that the rescue of the source phenotype
occurs due to the highly conserved nature of the duplicate protein genes. However, the incomplete
nature of this rescue and the partial cell viability defects are observed due to the few missense
mutations (although conservative) that have accrued in the duplicate genes. In cases where the amino
acid substitutions results in drastic changes in the duplicate protein, the DPI model would posit that
such a protein would be eliminated from the population due to its potential dominant-negative nature.
This might be one of the reasons why we only recover gene duplicates that are highly conserved in
terms of its sequence with respect to its source gene.
The cells which were not induced by the duplicate genes and had the source gene knocked out
survive presumably due to the same reasons as the knockout experiments discussed previously, as they
only received one of the two CRISPR gRNA pairs or none and thus were not edited correctly. We
confirmed cell viability using calcein-red AM for live cell staining. These images along with other
replicates of the RPS15 and RPS26 complementation experiments are shown in Figure S8-11.

4.5 Discussion
Based on our studies described in Chapter 2 and 3, we discovered thousands of retroduplicates
in the mammalian genome whose retention cannot be easily explained by the current models described
in the literature. We believe that the gene duplication model that we present in this chapter, not only
explains the retention of several previously unexplained gene duplicates, but also acts as a precursor to
majority of contemporary gene duplication models. The DPI model posits that gene duplicates are
retained in the genome not because they contribute to the fitness of the organism, but rather because
missense mutations in these genes are not tolerated due to dominant negative effects of missense
alleles. To evaluate this model, we test several predictions that can be made for the model. The unique
aspect of testing DPI model is that unlike other gene duplication models, that are almost exclusively
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theoretical, we designed in-vitro experiments to provide substantial support for the model along with
the in-silico testing.
We first tested whether dominant-negative effects play a role in limiting the number of gene
duplicates in a family. We confirmed that notion, as we observe that DN gene families are relatively
smaller in size than non-DN gene families. According to the DPI model, this observation is supported by
the fact that a lower entropy would be needed to maintain negative selection on smaller set of gene
family members. We also show that DN gene families are under stronger selective pressure compared to
non-DN gene families, further exhibiting the trend that DN gene duplicates tend to avoid nonsynonymous substitutions, which in turn extend their half-lives and their chances of being retained in
the genome, but not necessarily from a functional standpoint.
Furthermore, we test the DPI model by in vitro experiments, specifically testing necessity &
sufficiency of source genes and their gene duplicates. We pursued knockout experiments; where we
independently target the source gene and its respective duplicate gene. We show that knocking out the
source gene impairs the functions of cells drastically and that the loss of a conserved duplicate has little
to no phenotypic consequence. Next, we analyzed whether the gene duplicate’s induction in cells where
the source gene was knocked out, could potentially rescue the function of the cells. Our results showed
that the duplicate genes did partially recover the phenotype of their respective source genes, but it
comes with a fitness cost incurred due to the rare missense mutations present in the duplicate genes.
These mutations were found to be conservative mutations and the DPI model would predict little to no
recovery if the missense mutations incurred were drastic. Perhaps, the gene duplicates with the drastic
phenotypes have already been eliminated from the population as predicted by the DPI model.
Through a series of in silico and in vitro tests, we successfully explain the retention of thousands
of previously unexplained gene duplicates that were seen to be held under strong selective pressure and
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were not explained by any of the existing gene duplication models. The next challenge is to apply the
principles of population genetics to integrate the DPI model with current models of duplicate gene
retention. We attempt to begin this modeling using the foundation laid by Innan and Kondrashov in
their excellent review [88] of gene duplication that focuses our attention on the key phases that lead to
the stable preservation of a duplicated gene, namely, origin through mutation, a fixation phase when it
segregates in the population and a preservation phase when the fixed change is maintained. Another
factor to be exclusively considered for gene duplication is that it is important to study each duplication
event from the moment of its emergence.
In Figure 21, a preliminary population genetics representation of DPI model shows that a
duplicate gene, while accepting synonymous substitutions at a neutral rate, does not allow nonsynonymous substitutions to accrue in its attempts to avoid potential dominant-negative mutations.
This limitation in acquiring non-synonymous mutation allows the duplicate gene to be retained in the
population for a comparatively longer time while maintaining strong purifying selective pressure. This is
prior to acquiring a fate determining mutation, which may ultimately lead to any of the eventual fates
such as pseudogenization, gene conservation, subfunctionalization or neofunctionalization.
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Figure 21: Population Genetics representation of the DPI (Duplication, Purification and Inactivation) model. Two
cases have been represented in this figure where the dominant negative effect is in full effect; as seen in the top
panel and absent; as seen in the bottom panel. In the pre-duplication phase, the single-copy genotype (A) is fixed
in the population. When a duplicate arises, the fixation phase begins for the duplicate. The duplicate is most likely
to be lost to drift but can also achieve fixation. After the duplicated genotype (A–A) is fixed, the fate-determination
phase begins and continues until the fixation of a fate-determining mutation. (S) represents synonymous
mutations while (N) represents non-synonymous mutations. dN/dS ratio trends are represented by the panel in
green. DPI model explains how a duplicate could remain for an extended period of time, where it stays in the fatedetermination phase and is under strong purifying selective pressure while doing so.

So, in conclusion, the DPI model successfully explains the retention of thousands of highly
conserved gene duplicates that might not be functionally important to the organism, however, missense
mutations in these gene duplicates can exert severe dominant-negative effects on the source gene. The
DPI model addresses the missing evolutionary gaps in the field of gene duplication, as it focuses on the
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immediate fate of the gene duplicate and acts as a precursor to all the established gene duplication
models that deal with terminal fate of these duplicates.

4.6 Conclusion
The body of work presented in the first four chapters detailed an in-depth exploration in
evolution of RPG gene family evolution and testing of its findings on other mammalian gene families. It
culminated in framing a novel gene duplication model; that offers an explanation to some of the
duplicates that have an extended half-life prior to acquiring a terminal fate. In addition to this main
finding, we have made several contributions to fields of comparative genomics, gene family evolution
and ribosomal biology. Our first study of characterizing evolutionary history of ribosomal proteins is the
most comprehensive analysis done on mammalian ribosomal gene families to date. The datasets
generated from this study allowed us to formulate a formidable hypothesis for our gene duplication
model. Thus, these datasets and associated methods used to derive it would aid comparative genomics
and ribosome biology groups to investigate other pertinent research questions. The role of
retroduplication in shaping evolution of various gene families is an understudied topic as mentioned in
Chapter 1. The findings from Chapter 2 and 3 provides deeper insights in evolution of retroduplicates
that may have been missed in other gene family evolutionary studies and provides scientists working in
gene family evolution with an easily adaptable computational pipeline to use in the future.
The study detailed in chapter 4 evaluated the proposed gene duplication model with a rare test
of both in-silico and in-vitro predictions. Most of the gene duplication models rely heavily on
mathematical modeling and population genetics for validation. A true litmus test for a gene duplication
model is performing functional validation in a biological setting. Well-established gene duplication
models in the past have shown such biological validations as proof [84,86]. Using the revolutionary
CRISPR-Cas9 technology, we were able to create precise knockouts in highly similar loci of duplicate
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pairs. This technology enabled us to perform knockout and complementation experiments to support
DPI model. This pipeline can also be easily adopted to study the effects and limitations of DPI in other
mammalian gene families.

4.7 Future Directions
The results from our studies on gene family evolution, poses very interesting questions that
warrants further investigation. In our first study conducted, we implemented a novel framework to
reconstruct evolutionary history of duplicates in mammalian genomes. As described in Chapter 2, we
observed instances of incomplete clades in various gene family trees that led us to speculate probability
of gene loss in certain species. The gene loss could be due to loss of synteny or lack of annotation in
extant species. To confirm these possibilities, we propose to use a novel technique called “reverse
synteny”. This technique involves searching for expected syntenic neighbouring genes in genomes (part
of the clade) where we observed gene loss/failure. This would provide a clear picture of the fate of the
duplicate with the following possibilities. The duplicate could have been degenerated beyond detectable
limits of our gene family analysis pipeline or also undergone complete gene loss. Alternatively, this nondetection could be due to assembly issues of the genome and thus, the duplicate may be uncovered in
unassembled contigs. Finally, in a rare instance, the region in question could have undergone rapid
rearrangements that may have resulted in loss of synteny. The findings from these analyses would
further contribute to the existing body of work in characterizing evolutionary forces that govern gene
duplication and loss.
As shown in Chapter 4, we performed some preliminary analyses on gene families known to be
dominant negative. Since the list of gene families known to be dominant negative is not exhaustive, we
need to test more candidate gene families based on its propensity to be dominant negative. Dominant
negative effects are readily observed on gene families with similar properties/constraints like RPGs. One
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of the immediately discernable properties of RPG family is that it is part of a multi protein complex. This
also happens to be a hallmark of many DN genes [120]. Thus, in depth analysis (as shown in Chapter 2)
should be conducted on gene families that are part of multi protein complexes. These analyses would
provide more evidences and importantly more candidates to test using our in-vitro pipeline.
Pseudogenes are molecular fossils that can help shed light on the evolutionary trajectory of
various gene families [121]. This was evident from our analysis shown in Chapter 2. We observed
preliminary evidences of long periods of selective pressure having acted upon pseudogenes before they
were pseudogenized. Further in-depth analyses can be conducted on these pseudogenes to have a
deeper understanding on the precise evolutionary constraints acting on gene duplicates under the DPI
model. DPI model predicts that gene duplicates are protected from accumulating missense mutations by
either being subjected to strict negative selection or inactivation of the duplicate by allowing for an early
stop codon in the ORF. This prediction can be tested by applying evolutionary models to recreate the
sequence of events leading to pseudogenization in DN gene family pseudogenes. The expectation would
be that there would be a higher preference to incorporate an early non-sense mutation prior to any
missense mutation.
The final challenge will be to build on our preliminary population genetics model (shown in Figure
21) and develop a more robust population genetic model to explain the retention of all previously
unexplained gene duplicates in mammalian genomes. We would like to model these gene duplicates and
provide probability of achieving all the fates, namely pseudogenization, gene conservation,
subfunctionalization and neofunctionalization, using various iterations and simulations of population
size, mutation rate and selection. The main goal is to precisely set up simulations to test the predicted
half-life of gene duplicates under different regimes of purifying selective pressure. As shown in Figure
21, we have begun establishing a population genetics model; however a more in-depth study is
required. We can begin by setting up the basic assumptions of the model and enhancing its applicability
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by following the principle of the Hughes (1993) gene duplication model [122]. This model emphasizes
purifying selection in the early stages of duplicates genes, motivated by several observations that are
not fully consistent with the strict model of Ohno. It is important to study this model as some of these
inconsistences match up with the predictions of the DPI model, especially the study in which they found
evidence for purifying selection against amino acid changes in both copies of most of the duplicated
genes created in the tetraploidization event of the Xenopus laevis frog species [122].

Chapter 5: Using ribosomal protein gene expression as a quality control
for single cell RNA-Seq
5.1 Introduction to Single Cell Transcriptomics
The recent rise in prominence of single cell biology can be readily explained by decades-long
observations of cell-to-cell variability in populations assumed to be homogenous. In 1957, it was
discovered that induction of the beta-galactosidase gene increased the proportion of cells expressing
the gene rather than increasing each cell’s expression level equally [123]. The stochastic nature of gene
expression in cells has been well documented in all forms of life ranging from prokaryotes, unicellular
eukaryotes to mammalian cells [124–126]. In the recent past, plenty of single cell RNA-Seq studies have
been published on dissecting cell populations of developing tissues. These tissues have heterogeneous
mix of cells at asynchronous states of development. Thus, it becomes necessary that gene expression is
measured at a single cell level to avoid averaging effects of bulk expression from such cell populations
[127]. Along with technological advancements that have enabled precision capture of single cells,
computational tools to analyze gene expression data from single cells are being developed at a rapid
pace [128].
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5.1.1 Types of Single Cell RNA-Seq Technologies
The typical workflow for single cell RNA-Seq (scRNA-Seq) experiments involve precision capture
of single cells, extraction of RNA from each single cell, preparation of RNA library using reverse
transcription followed by amplification and finally sequencing of the RNA library. Single cells are
generally captured in a high-throughput manner either using FACS or microfluidic systems. FACS
provides the ability to sort single cells based on surface markers, but introduces more shear force than
microfluidic systems. This may lead to lower cellular integrity in more sensitive cells, thereby causing
loss of cytoplasmic mRNA. Certain microfluidic devices such as the C1 microfluidic system allows for
staining based visual inspection of the single cells to discriminate between single vs multiple cells and
live vs dead vs debris cells [129]. Visual inspection involves manual labor to make these calls and is not
feasible for large scale studies. There are also microfluidic devices based on drop-seq technology that
provide more high throughput capture of cells in a single experimental run [130]. However, in this
technology, the library quality of each single cell is assessed by various transcriptome signatures post
sequencing. Even with microfluidic platforms involving visual inspection, it has been shown that visual
inspection alone is not sufficient for assessing RNA library quality in single cells [129,131]. For example, a
single cell characterized as a dead cell in a staining based visual assay, could still have a relatively intact
RNA library within it if the cell death occurred just prior to RNA extraction step. On the contrary, a single
cell labelled as a ‘live’ cell, could have a leaky cell membrane leading to loss of cytoplasmic RNA.
Therefore, for future large scale scRNA-Seq studies, the ideal solution would be to use various gene
expression signatures in the transcriptome to unambiguously discriminate between a good and bad
quality RNA library.
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5.1.2 Different types of scRNA-Seq quality control approaches
Different studies have incorporated a wide array of quality control (QC) features to discriminate
between technical and biological variation in single cell gene expression. Technical variation could be
due to scenarios such as, but not limiting to, batch effects, damage to the cells during the capture step
resulting in reduced RNA content and capture of multiple cells instead of one. One of the widely used
metric is number of genes expressed in each single cell [132]. The rationale for this metric is that a bad
quality single cell library would contain lesser number of genes with detectable expression compared to
that of a good quality single cell library. Unfortunately, this metric performs poorly in experiments
involving heterogeneous cell types with varying number of genes expressed in each cell type. Thus, it
becomes difficult to discriminate between cells having inherently low number of genes expressed vs
damaged/dead cells and on the other end of the spectrum, single cell libraries with inherently high
number of genes found to be expressed vs libraries containing multiple cells. It has also been shown that
housekeeping genes have varying levels of expression across different cell types and they cannot be
used as a reliable metric as well [133]. One of the promising QC metrics currently in use is measuring the
number of reads that map to mitochondrial genome [131]. A dead cell will have relatively more reads
mapping to mitochondrial genome compared to a live cell. This is due to the fact that loss of
mitochondrial transcripts would be minimized by the additional protection offered by the mitochondrial
membrane in the event of damage to the cell. Although this metric is effective in discriminating dead &
debris vs live single cells, it is ineffective in resolving single vs multiple cells. Resolving single vs multiple
cells has been an Achilles’ heel for many QC metrics used in literature. At this current juncture, manual
visual inspection of single vs multiple cells is the most effective solution. As discussed above, it is not a
scalable model and recently it was discovered that the C1 microfluidic system contained a design flaw
that made it difficult to visually discriminate between single vs multiple cells (with a probability of upto
40%) [134].
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All of the above mentioned points indicate the necessity to formulate a standard QC workflow
for scRNA-Seq that will enable precise selection of good quality RNA libraries using transcriptome
signatures. To this end, a recent effort was undertaken to combine commonly used metrics and other
novel informative metrics to accurately classify good quality scRNA-Seq libraries [135]. This approach
involved training a QC model in a SVM machine learning framework with metrics found to be highly
statistically significant in resolving good vs bad quality libraries. A mES scRNA-Seq dataset was chosen as
a training dataset and the visual QC calls made using the C1 microfluidic chip was used as ground truth
to evaluate the model. Although this model was shown to be more effective compared to other QC
approaches used till now, it suffered from a huge overfitting issue. Because the model was trained on a
mouse dataset, it performed poorly in human scRNA-Seq datasets. The authors of the study
acknowledged this issue and offered a solution for training a new model each time a different organism
or even a specialized cell type like cancer cells are used. This solution of training a new model for even a
slight modification of experimental approach is inefficient and hugely time consuming. Thus, there is a
need for a universal metric that would work irrespective of experimental variables in scRNA-Seq
experiments.
5.1.2 Use of RPGs to serve as a scRNA-Seq QC metric and scope of study
Based on our prior work involving in-depth study of ribosomal proteins, we hypothesized that it
may serve as a good candidate for assessing library quality in single cells. One of the primary reasons for
our choice is that ribosomal proteins have a biological constraint to maintain co-regulated expression,
which could serve as a good indicator of cell health. Another striking feature is that ribosomal proteins
are expressed at very high levels due to their integral function in the cell. This feature may also enable it
to serve as a QC metric for scRNA-Seq performed at lower read depths. As shown in our previous work,
evidence of transcription was observed in some RPG duplicates, which may hinder in measurement for
RPG co-expression in RNA-Seq. In a recently published study, epigenetic data was used to correlate RPG
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expression [136]. The authors of this study conclude that only a handful of RPG duplicates (n=7) have
the same epigenetic profile as parental RPGs across several human tissue types.
The patterns described above were primarily based on our understanding of ribosomal protein
gene expression in bulk datasets. Thus, there is a need to independently study these findings in single
cell datasets. The evaluation and testing of RPs as a viable metric for predicting library quality in scRNASeq is discussed in further sections.

5.2 Study of RPG expression in single cells
5.2.1 Expression of RPGs in bulk and single cell datasets
The first test for utility of RPGs as a QC metric involved assessing its relative expression level in
the transcriptome of various tissues or cell types. We utilized two publically available datasets, one a
bulk dataset from the BodyMap project and another a single cell dataset characterizing a developing
lung tissue in E16.5 mouse (see materials and methods). The processed expression tables downloaded
for these two datasets were used to plot the relative expression of RPGs, its paralogs predicted to have
robust expression [136] and the whole transcriptome as shown in Figure 22. Parental RPs were found to
be expressed at very high levels and the distributions of three gene sets in both bulk and single cell
datasets were significantly different (Levene’s Test Pr(>F) : < 2.2e-16). It is also interesting to note that
most of the duplicate genes do not have detectable level of expression in the single cell dataset. Based
on evidence of robust expression of parental RPGs in these two datasets, it was picked as a candidate
set for further downstream analyses.
The next test was to assess the co-regulation of RPGs. Figure 23 (A & B) shows a correlation
heatmap and a histogram of correlation values for all RPG pairs in the two datasets studied. Coregulated expression constraint can be clearly seen from these figures, but single cells have lower
correlation values compared to bulk dataset (one sided KS-test p value < 0.01, figure 23 C).
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A) Bodymap dataset (Bulk data)

B) E16.5 Mouse lung single cells (Single cell data)

Figure 22– RPG expression levels across single and bulk datasets. Box plot showing relative expression levels of
source & duplicate RPGs with respect to all genes in the transcriptome for bulk (A) and single cell datasets (B).
Expression values (RPKM) are in log2 scale and the number of genes detected for each gene set is shown in x-axis.
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The same trend was observed even when single cells of the same sample size as the bulk dataset (n=16)
were randomly chosen and bootstrapped (100X) to perform the above mentioned analysis (data not
shown). The lower correlation values in the single cell data can be partly explained by stochastic
expression of single cells at different points in cell cycle, whereas bulk expression represents an average
expression of single cells under different phases of cell cycle. Thus, single cell gene expression tends to
be noisier than bulk tissues.
A) Body Map Human 16 Tissues RPG Correlation (Bulk)

B) E16.5 Mouse Lung Single Cell RPG Correlation (n=139)
(cells=148)

C) Comparison of correlation values between bulk and single cell datasets

Single Cells
Bulk

Figure 23– RPG correlation in Bulk vs Single cell data. A) Bi-clustered heatmap of pairwise RPG correlation values
for bulk dataset comprising of 16 tissues (A) and single cell dataset of 139 cells (B). Pairwise correlation values for
both datasets are shown in the density histogram plot (C).
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5.2.2 Influence of RP paralogs on quantifying RPG expression in RNA-Seq
As seen in Chapter 2, mammalian genomes contain thousands of intact or pseudogenized
duplicates of RPGs interspersed at different locations. This poses a conundrum when mapping reads of
RPGs from RNA-Seq to the target genome as the parent and the duplicate genes are highly similar and
thus resulting in multi-mapped reads. Existing RNA-Seq analysis pipelines employ a variety of techniques
to counteract these anomalies. For example, some of these involve choosing the best loci based on
sequence similarity, discard multi-mapped reads or weight multi-mapped reads using various statistical
approaches [137]. Unfortunately, all these methods lead to under/overestimated expression of RPGs.
The presence of RPG paralogs in the human genome and its effect in RPG expression quantification in
RNA-Seq was discussed in detail in a recent publication [136]. The authors’ main finding was that a
better co-regulated RPG expression pattern was uncovered when reads from a human RNA-Seq dataset
were mapped to human genome masked for non-expressed RPG paralog loci as opposed to mapping to
whole genome. A reprocessed data from this manuscript shows higher correlation values for RPGs;
when reads are mapped to the masked human genome in comparison to the unmasked human genome
(Figure 24) (one sided Mann-Whitney-Wilcoxon Test p-value < 0.01).

Unmasked Genome
RPG paralogs
masked Genome
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Figure 24– Comparison of pairwise RPG correlation between two genome targets. Density histogram showing
RPG pairwise correlations computed from Body Map RNA-Seq reads mapped to RPG paralog masked human
genome (red) and complete human genome (blue).

The negative influence of these RPG paralogs in measuring co-expression of RPGs provided the
necessary impetus for our RPG QC method to incorporate a more accurate approach to quantify
expression of RPGs in RNA-Seq datasets. To that end, we created a standalone RPG exome that only
contain parent RPG loci. This standalone RPG exome was generated for all genomes utilized in the study
and used to map RNA-Seq reads to unambiguously measure expression of RPGs.

5.3 Training a RPG QC model
A SVM classifier (see material and methods section) was initially chosen to perform classification
of low and high quality library preps in single cell datasets, as used similarly in a recent work mentioned
above [135]. To have an unbiased test of the model, it was important to choose appropriate training and
test data for our study (See material and methods section). The main criteria for choosing these datasets
was to have an established ground truth in the form of visual microscopic analysis done in C1microfluidic systems. Although this may not be truly accurate (see section 5.1.1), it is the best available
option currently. The datasets chosen contain multi-class classification of cells based on visual
inspection (Live, Dead, Empty, Debris and Multiple). We decided to train our SVM classifier with a simple
binary classification of good vs bad quality cells to start with. To further elaborate, all the cells that were
classified as single and live cells by visual inspection were labelled “good” and all the other categories
were labelled “bad”.
5.3.1 Selection of highly informative RPG features
In order to achieve optimal performance in the SVM, it is imperative to use non-redundant
features. In other words, multicollinearity among features need to be avoided and all features extracted
from RPG expression pattern must be evaluated for it. To this end, variance inflation factor (VIF) was
used to quantify collinearity in RPG features. This test was performed on the training dataset by
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extracting 5 features from RPG expression values (mean, standard Deviation (SD), coefficient of variation
(CV), variance, frequency of RPGs detected in sample). Based on this analysis, we found that mean, CV
and frequency of detection of RPGs were highly informative (data not shown).
The highly informative RPG features were then compared with a cohort of QC metrics found to
be statistically significant in a recently performed study [135] (supplementary figure 12). The features
and model from this study will be termed Illicic et al., model hereafter. As seen in the figure, RPG
features CV and frequency of detection were found to perform better than all other QC metrics. Yet, it is
important to note that any one feature is not sufficient to discriminate between good and bad quality
single cell library.
5.3.2 SVM run to evaluate influence of genome target and read depth
As mentioned earlier, the presence of paralogs in the mammalian genome results in under/over
estimation of RPG expression values. We evaluated how this would affect the performance of the SVM
classifier by performing training and testing on the same dataset (Training Dataset). This test was done
across two genomes (RPG exome and Whole genome) at various read depths (Figure 25).
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Figure 25 – Evaluation of SVM model across various read depths and gnome targets in training dataset. Plot of
sensitivity and specificity for evaluating stability of SVM model across low to high read depth and with presence
(whole genome) & absence of RP pseudogenes (RPG exome).

Although both our hypotheses of the model performing invariable of read depth and having
differential performance due to target genomes seem to be supported by our results, the overall
performance of the model is on the lower end compared to Illicic et al., model (when also trained and
tested on training data). This is clearly shown by relatively lower sensitivity values across all conditions.
The better performance of Illicic et al., model within the training set could be partly due to the
additional step of using an outlier method to filter bad libraries prior to training with the SVM classifier.
Nonetheless, we proceeded to test for the stability of this model across various test datasets with the
prediction that it would have much more stable performance compared to Illicic et al., model.
As seen in Figure 25, RPG SVM classifier generated by RPG exome mapping has higher sensitivity
compared to whole genome mapping, despite being trained and tested on the same dataset. Thus the
former classifier was applied to the test datasets and its performance was evaluated. A summary of
these results are shown in a bar chart (figure 26). Unfortunately, the performance of the SVM classifier
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is very low across all the test datasets. Of particular note, a low sensitivity score is seen for the test mES
dataset even though the SVM model was trained on a similar mES dataset. Also, the SVM model
completely fails to classify low quality cells in human Hela cell dataset. The results obtained point
towards huge over-fitting issues known to arise in SVM trained models.
Test Data – SVM Performance evaluation

Figure 26 – Evaluation of SVM model across various test datasets. Bar chart showing sensitivity and specificity of
the RPG SVM model computed for various single cell test datasets. RPG SVM model was run for the entire set of
reads using RPG exome as genome target.

On further trouble shooting this anomaly, we observed that the RPG features are still powerful
in resolving bad quality libraries. Based on the 3D plots, we observed that the low quality cells are
generally far removed from a tight cluster of high quality single cells (supplementary figure 13).
Unfortunately, SVM classifier fails to classify low quality cells that follow this standard data pattern. This
finding presented an opportunity to explore other classifiers that are more sensitive in leveraging this
pattern.

5.5 Multi-variate Outlier Model as an Alternative
Most of the current QC approaches uses one or an iterative approach of using multiple metrics
independently to assess library quality [132]. These approaches usually use a standard univariate outlier
detection method. The principle behind the method is to remove data points that lie far away from the
main distribution. This is usually based on a threshold like standard deviation. Though this method might
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seem limiting when confronted with datasets having large quantity of low quality datapoints, there are
some statistical preprocessing steps that can be done to mitigate this limitation. A commonly used
method is to use mixture modelling to detect multi-modal distributions. One of the distributions that fall
under the expected range of values is then chosen for removing outliers. Robust statistical methods for
multivariate outlier detection are available and one of the widely used tool with this regard is mvOutlier
[138]. This method employs robust mahalanobis distance based on the mcd estimator and uses
correlation between the variates to compute outliers. Since it is a non-parametric method, normality is
not assumed in the datasets. This tool is also used to remove outliers prior to checking for normality in
multivariate data [139].
5.5.1 Performance of RPG-mvOutlier across datasets
The same datasets, features and performance criteria used for training and testing the SVM
model were also used to test the mvOutlier based model. As seen in Figure 24, a similar analysis was
conducted for mvOutlier model with RPG features to evaluate performance across read depth, genome
targets and various scRNA-Seq datasets (supplementary figure 14). Based on the results from
supplementary figure 14, no clear trend could be observed for the influence of genome target on
mvOutlier performance. Also of important note, uniform performance is observed across all read
depths. Thus, whole genome was used as mapping target for mvOutlier model.
To truly test the performance of RPG features in our outlier model, we compared its
performance to highly informative features extracted from Illicic et al., and both sets of features
combined (Figure 27). As seen in figure 27, supplementary figure 15 and supplementary table 5; both
feature sets performed at comparable levels across all datasets and read depths. RPG features have
marginally better specificity values compared to other feature sets. RPG features and Illicic et al.,
features both register low performance on correctly classifying multiple cells as low quality cells
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(supplementary table 5). This is clearly evident from the mouse pancreas dataset that contains high
number of multiple cells that have been accurately annotated.
mvOutlier performance across various scRNA-Seq datasets and library QC features

Figure 27 – Evaluation of mvOutlier model across various scRNA-Seq QC feature sets. Barplot showing sensitivity
and specificity of mvOutlier model across RPG features, QC features found to be statistically significant in Illicic et
al., study (Non-RPG Metrics) and a combination of the two feature sets (RPG + Non RPG Metrics). The QC features
were computed from scRNA-Seq reads mapped to whole genome for all reads in respective libraries.

5.6 Discussion
In this study, we have demonstrated the utility of features extracted from RPG gene expression
as a QC metric in scRNA-Seq. RPG expression pattern is conserved across vertebrate species along with
sequence homology. As seen in the study, RPGs are ubiquitously expressed in all cell types with high
levels of expression. These properties theoretically make it an excellent choice for using it as a QC metric
in RNA-Seq experiments for diverse cell types. The presence of large number of paralogs in RPG family
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poses a formidable question on the effectiveness of current RNA-Seq pipelines to unambiguously map
RNA-Seq reads to the right loci. A combination of applying apriori biological knowledge, applying more
sensitive alignment/mapping tools and supplementing with robust statistical methods could serve as a
good solution. A testament to this approach, our quick fix of aligning the RNA-Seq reads to only a subset
of biologically relevant RPG loci showed improvement in the SVM classifier performance (Figure 24).
Though the SVM classifier did not yield any productive results, further exploration of different
machine learning methods would likely yield fruitful results in the future. The failure of the SVM
classifier led us in to exploring other types of classifiers that can best leverage the data pattern we
observed in our 3D scatterplots (supplementary figure 13). A multivariate outlier detection method was
found to be an ideal choice for this purpose. One of the salient features of a outlier method is that it is
relatively less influenced by experimental variables as opposed to other machine learning classifiers that
are subject to overfitting issues when trained in one dataset and tested across datasets with even
slightly different experimental conditions from the former. Although machine learning classifiers such as
SVM boasts higher performance in conditions similar to the dataset it was trained on, the quick and
universal application of outlier methods makes it a practical choice in the current scenario.
The results from the outlier approach show the stable performance of the method across
different test datasets. The least performance is seen in the dataset containing a large class of multiple
cells compared to other datasets. This could be due to the fact RPG features that are currently used is
not sensitive enough to discriminate between multiple and single cells. Multiple cells represent an
average expression profile of single cells and as seen in the 3-D plot of RPG features for the pancreas
test data (supplementary figure 16), a major subset of multiple cells have a tighter cluster compared to
single cells. Perhaps, using other features that can better discriminate single vs multiple cells in
combination with RPG features could result in a better performance of the model. Another solution to
this problem could be designing better single cell sorting platforms that minimizes incidences of multiple
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cells (multiplets). In a recent publication, it was shown that rate of multiplets can be reduced to as low
as 1.6% when the recommended experimental protocol is followed for the 10X chromium single cell
workflow [140].
Though we were not able to show any significant difference in performance between RPG QC
features compared to Illicic et al., QC features, we hope further studies involving testing of wide array of
datasets would provide additional support to RPG QC features.

5.7 Conclusion and Future directions
5.7.1 Conclusion
Our in-depth analysis of RPG family evolution in mammalian genomes (Chapter 1 – 4) enabled
us to build an expansive knowledge-base about RPGs. This led us to framing a hypothesis that the
evolutionarily constrained co-expression of RPGs could translate into a viable metric for evaluating
library quality in scRNA-Seq studies. Formulating a standard QC approach to evaluate library quality in
scRNA-Seq studies is crucial for accurate interpretation of results post analysis. In other words, failing to
discern between technical and biological variation would lead to highly misleading findings and thus
render it difficult to achieve concordant results between studies. We believe our study to formulate a
scRNA-Seq library QC approach using a highly conserved network of genes is the right step in the
direction of establishing a gold standard for the scRNA-Seq community.
We made an important and also interesting observation in addition to the main problem
addressed. The under/over estimation of RPG expression in many of the RNA-Seq pipelines is highly
concerning given the fact it confounds biological expectation. Thus, we have thrown light to a long
standing problem of reconciling accurate expression pattern between paralogs in the genome. The
counter-measure we have taken in this study should be a good guide to the wider RNA-Seq community
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to adopt a more stringent approach of annotating valid transcriptional regions in the genome and
mapping only to that subset. Such measures would reduce the incidence of multi-mapped reads and
therefore increase the accuracy of gene expression quantification.
In this study, we make a valid argument for utilizing RPG expression pattern as QC metric by
showing its robust performance across various datasets. Although our initial approach of using binary
SVM classifier did not provide fruitful results, it helped us in formulating a practical strategy of using an
outlier detection algorithm to make relatively more accurate calls. We demonstrate that the power of
an outlier classifier can be highly enhanced when used with appropriate features. We also perform a
series of tests with wide variety of datasets, rarely seen in other studies that evaluate library quality QC
performance.
5.7.2 Future Directions
Our QC model and other approaches fail to discriminate between the signals of single vs
multiple cells. While there was an appreciable effort by Illicic et al., (personal communication) based on
performing feature selection using Gene Ontology (GO) based gene groups across good vs multiple cells;
a solution was not found. Finding a combination of features to accurately discriminate between multiple
vs single cells and simultaneously other bad quality cells would greatly benefit the scRNA-Seq
community. This is especially important when considering the sample size trade-off between the high
precision capture of single cells through the C1-fluidigm system versus relatively low precision drop-seq
based systems. Thus, choice of a particular platform should not be a limiting factor for a scRNA-Seq
study.
Though we showed that the outlier model performed robustly compared to the SVM model, the
utility of machine learning models is far reaching than outlier approaches. To further elaborate, outlier
models can only perform a simple binary classification, but machine learning models such as SVM have
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the capability of performing multi-class classification [141]. Multi-class classification would allow to
classify low quality single cells in to categories such as dead, debris and multiple. This then enables the
researcher to make informed decisions in discarding low quality cells and also provides critical
information on technical biases inherent in the experimental approach. For example, if a workflow
inadvertently creates a bias for capturing more than usual amounts of multiple cells, a multiclass QC
classifier would allow a researcher to uncover this bias. In order to achieve this goal, various classifiers
along with their parameters need to be evaluated for robust performance across different datasets
[142].

Chapter 6: Materials and Methods
6.1 Chapter 4 materials and methods
6.1.1 Data Collection for DN and Non-DN Negative Gene Families
Gene family definitions were obtained from Ensembl for four mammalian species Human,
Monkey, Rat and Dog. Only gene families containing members in all four species were selected. Since,
gene families are groups of homologous genes that are likely to have highly similar functions, guilt by
association principle was used to assign an entire family as Dominant Negative (DN) gene family if at
least one member was annotated as such in OMIM database. This resulted in 465 DN and 9362 non
dominant-negative (non DN) gene families. Putative duplicates and pseudogenes were added to the
gene family to create a super-gene family, using definitions from Pseudopipe database.
6.1.2 DN and NON-DN Selective Pressure Calculations
Gene trees were obtained from the pipeline described in Figure 11 of Chapter 4 and basic
premise of the selective pressure calculations was adopted from our previous publication [114]. Multiple
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sequence alignment (MSA) for each gene family was done using MACSE (reference) to account for
proper alignment of full length genes with pseudogene members. The gene tree and MSA were then
used as input for CODEML package in PAML to generate single omega value for each gene family.
6.1.3 Cell Culture
HEK293T (human embryonic kidney 293T) cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% FBS (fetal bovine serum), 100 units/ml penicillin and 100
µg/ml streptomycin with 5% CO2 incubation.
6.1.4 Construction of Plasmids
6.1.4.1 CRISPR vector and sgRNA design
For all our genome engineering experiments, we followed the CRISPR-Cas9 system protocol
provided by the Zhang Lab at the Broad institute (Ran et al. 2013). The pSpCas9n (D10A) expression
vector (Addgene plasmid # 48141) carrying a codon-optimized Cas9 gene was purchased from Addgene
(http://www.addgene.org) for increased targeting specificity (Vector map is shown in Figure S6). The
construction of the gRNA expression vector was based on the method shown on the Addgene website
(http://www.addgene.org/static/data/85/85/e19394c4-5e76-11e2-a7c4-003048dd6500.pdf).

Source

and duplicate gene sgRNA sequences were designed using CRISPR design tools CHOPCHOP and DNA2.0.
Specific care was taken to make sure that the target sequence was immediately preceded by a 5’ NGG
PAM sequence, and the 20-nt guide sequence base pairs with the opposite strand to mediate Cas9
cleavage at ~3bp upstream of the PAM. All the sgRNA designs and sequences are listed in Table S3 and
more details about their design strategies are discussed in Figure 12. These sequences were cloned into
the Cas9n vector using the protocol from Feng Zhang's lab. These recombinant plasmids were amplified
in Escherichia coli and finally purified using a QIAGEN Miniprep Kit.
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6.1.4.2 Inducible transgene expression vectors
Expression vectors for candidate ribosomal protein RPS15 and RPS26 source and duplicate
genes were constructed by inserting each cDNA into a piggyBac cumate switch inducible vector (System
Biosciences, Mountain View, CA, USA; Vector map is shown in Figure S7). All of the plasmid vectors were
confirmed by DNA sequencing.
6.1.5 CRISPR/Cas9n transfections for gene knockout experiments
Cells were transfected using Lipofectamine 2000 (Life Technologies) at 80%–90% confluency
following the manufacturer’s recommended protocol. A total of 500 ng Cas9 plasmid and 100 ng of U6sgRNA PCR product was transfected. CRISPR positive cells were selected by puromycin selection. These
cells were then confirmed by Sanger DNA sequencing.
6.1.5.1 Clonal isolations of cell lines and functional testing
Isolation of clonal cell lines were achieved by FACS using GFP selection, followed by an
expansion period to establish a new clonal cell line. Genomic DNA was extracted using the Qiagen
DNeasy Blood and Tissue kit and gene-specific primers were used to amplify the DNA sequences.
Targeted genome modifications were detected by Sanger DNA sequencing.
6.1.5.2 Inducible transgene expression
complementation-rescue system

and

subsequent

CRISPR/Cas9n

transfections

for

the

Cells were seeded into 6-well plates (Corning) at a density of 20,000 cells/well, 24 hr prior to
transfections. HEK293T cells were transfected with plasmid vectors using the Lipofectamine 2000
reagent (Invitrogen) according to the supplier's recommendations. In brief, the cells were plated on to 6well dishes and transfected with 2 μg of plasmid DNA mixed with 5 μL of Lipofectamine 2000 for the
experiments. To establish stable inducible cell lines, positively transformed cells were selected using
puromycin (2 μg/mL). Since the inducible piggyBac vector features a tight cumate switch combined with
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an EF1-CymR repressor-T2A-Puro cassette for the establishment of stable cell lines, cumate solution
(System Biosciences) was added to the puromycin-selected cells for inducing transgene expression.
Polyclonal cultures were generated by continued selection under puromycin selection. For the
complementation experiments, CRISPR pSpCas9n transfections were performed in the same manner as
described above. Full pipeline of the complementation experiment can be seen in the Figure 12.
Additionally, for the complementation rescue experiment, we replaced the antibiotic selection from
puromycin to hygromycin in the Cas9n vector in order to select cells using dual selection of hygromycin
(Cas9n vector) and puromycin (piggBac vector).
6.1.6 Cell Viability Tests and Data Analyses
For crystal violet dye cell quantification assay, cells were washed twice with 1X PBS and fixed
with 20% methanol solution for half an hour at room temperature. Cells were stained with 0.5% crystal
violet solution for 30 min at 37 C. Stained cells were washed with water until a clear background was
visible. Crystal violet absorbance was determined using a microplate reader at 550nm (Varioskan Flash,
Thermo Scientific, USA). For live cell stain and viability quantification, fluorogenic esterase substrate
Calcein red-orange AM was passively loaded into viable cells. Cells were washed twice with 1X PBS and 5
ml 0.5 mM working Calcein solution was added to 1 ml serum free media (1:200, 2.5 mM) and were
incubated at 37 C for 1 hour before cell imaging.

6.2 Chapter 5 materials and methods
6.2.1 Gene Expression datasets
Processed gene expression data tables were obtained from Bodymap (GSE30611) and a single
cell dataset characterizing embryonic mouse lung cells [143]. These datasets were used to characterize
RPG expression in both bulk and single cell tissues.
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To train and evaluate the performance of different QC models tested in this study, a training
dataset and a diverse set of test datasets were picked. The training dataset was chosen based on the
criterion that it provides a good representation of all data classes present in a typical scRNA-Seq study. A
mES scRNA-Seq dataset used as a training set in a similar study [135] was chosen as the training set in
this study. Choosing a collection of test datasets that represents all possible scenarios is essential for
unambiguously evaluating the performance of a model. To this end, a set of scRNA-Seq datasets
encompassing different species and cell types were chosen as shown in Table S4. One of these datasets,
a scRNA-Seq dataset characterizing pancreatic single cells in mouse has accurate representation of
library preps extracted from multiple cells based on highly reliable biological signals [131]. This allows
for true evaluation of performance of the model in distinguishing single vs multiple cells.
6.2.2 Gene expression quantification
scRNA-Seq datasets used for evaluating our models were reprocessed by our in-house RNA-Seq
pipeline for uniform analysis. The raw reads were mapped to appropriate genomes (Ensembl human and
mouse) using Hisat2 [144]. Whole genome and a manually curated RPG exome were used for both
species. RPG exome consists of a GTF file annotating all the source RPG genes. Gene expression values
were expressed in TPM using isoEM2 [145]. This RNA-Seq pipeline was run on in-silico subsampled reads
(100K,200K,400K,1600K) to mimic low read depth scRNA-Seq libraries in addition to using all the reads
present in the library.
6.2.3 Performance criterion
The performance of the training and test datasets (see 6.2.2) were evaluated based on the
results from the following confusion matrix,
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Predicted

Low Quality Cells

High Quality Cells

Low Quality Cells

True Positive (TP)

False Negative (FN)

High Quality Cells

False Positive (FP)

True Negative (TN)

Truth

Here TP refers to number of low quality cells and TN refers to number of high quality cells. Thus,
Sensitivity refers to the proportion of correctly classified bad quality cells and specificity points to
proportion of correctly classified good quality cells. Ideally, both these values should be close to one,
which indicates a good performing model.
6.2.4 Classifiers
Functions part of ‘e1071’ R package were used for running a binary SVM classifier [146]. The
three parameters part of the radial SVM framework were tuned using grid search and cross validation
(also part of ‘e1071’ R package). To avoid overfitting of the SVM model, this tuning process was
performed 50 times. The performance metrics calculated were an average of these 50 parameter sets.
mvOutlier R package [138] was used for detecting outliers using the same features that were
part of the SVM classifier. Multimodal distributions were detected using a normal mixture model and
samples part of the outlying distributions were labelled as outliers. The performance criteria used to
evaluate the SVM model (see 6.2.3) was also utilized for this method. The highly informative features
that were used in Illicic et al., SVM model were used to generate a separate mvOutlier model for
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comparison. The features are namely number of reads mapped to genome, percentage of reads
mapping to mtDNA, genes related to Cytoplasm function (GO Term), downregulated mitochondrial
genes and transcriptome variance [135]. The two feature sets mentioned above were combined to
evaluate its joint performance in mvOutlier.
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Chapter 7: Appendices
7.1 Appendix I – Ribosomal protein gene family trees
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7.2 Appendix II – Supplementary figures

Figure S1: Observed frequencies for RNA-mediated duplicates are much higher than expected frequencies in RP
families. Observed frequencies and expected frequencies (in brackets) shown for each speciation node for 5
mammalian genomes. The values were generated using data table created in Jun et al. [55]. Observed frequencies
for RT-RPs were derived from ribosomal families (Number of RT-RPs/Total Number of Duplicates in RPs) and
expected frequencies for intact retroduplicates were derived from 8872 non-ribosomal gene families (Number of
RTs in non-RP gene families/Total Number of duplicates in non-RP gene families). All diversification times are from
Ureta-Vidal et al.[42].
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Figure S2: No Species-specific bias seen based on duplicate fates in ribosomal protein gene families. Distribution
of duplicates (annotated by fate) across 8 mammalian species. DD-RPs, RT-RPs and R-RPs are shown in blue,
green and yellow respectively.
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Figure S3: High sequence conservation observed across all duplicate fates in terms of pairwise distances.
DD-RPs and RT-RPs were seen to be under comparatively stronger conservation than R-RPs. Using pairwise
distances instead of Ka/Ks ratios as seen in figure 4. Error bars represent 95% Confidence Interval.
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Figure S4 - Gene Tree for RPL10A showing PAML branch specific omega values leading up to a clade. An abridged
gene tree of RPL10A generated by parsimony-based syntenic method [10]. The branch specific omega values are
listed at each node in purple. Ka/Ks values are represented at all leaves in green. The RT-RP duplicates and their
omega values are highlighted in red.
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(A)

(B)

Figure S5: Sequencing Alignments of clonally isolated HEK293T cells in which source and duplicate genes were
knocked out respectively. The alignments were performed to observe the whether the surviving cells received the
deletions/manipulations correctly or were escapers. For example, the cells in which RPS15 source genes were
knocked out and survived did not receive the deletions correctly and hence were viable, as seen in part (A) of the
figure. The cells in which RPS26 duplicate genes were knocked out and survived had received the knockout
correctly and were still viable, as seen in part (B) of the figure.

Figure S6: Vector PX462 is the CRISPR-Cas9n vector for our knockout experiments, as mentioned in Materials
and Methods.
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Figure S7: Vector PBQM812A-1 is the cumate inducible PiggyBac vector for our complementation rescue
experiments, as mentioned in Materials and Methods.

Figure S8: Replicates of RPS15 and RPS26 CRISPR-Cas9n knockout experiments.
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Figure S9: Replicates of RPS15 at two timepoints for the Complementation-rescue experiments.
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Figure S10: Replicates of RPS26 at two timepoints for the Complementation-rescue experiments.
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Figure S11: Calcein live cell imaging examples to confirm viability.

Figure S12: Univariate performance of RPG features + Other QC features. Each box plot represents distribution of
values of a QC feature across single cells in the training data. Each plot is divided based on ground truth
classification of cell quality as seen in C1 microfluidic system. p-values (wilcox test) calculated from comparing the
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distributions of Good vs Bad quality single cells are provided within brackets. The plots/features are arranged in
ascending order from left to right (row wise) based on these p-values. The right bottom corner tile represents the
sample breakdown for each cell quality category.

Figure S13: 3D plot of RPG features extracted from Training data mapped to RPG exome. All three RPG features
are shown in log2 scale for all single cells in the scRNA-Seq training dataset. The red and blue data points denote
high and low quality single cells based on C1 system annotation.
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Figure S14: Evaluating influence of genome targets on RPG mvOutlier performance. Each plot represents
performance of mvOutlier under different genome targets (whole and RPG exome) for a scRNA-Seq dataset. The
performance was evaluated on 4 different read depths as shown in x-axis.
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Figure S15: Performance of different feature sets under mvOutlier model across various scRNA-Seq datasets.
Each tile shows the performance of RPG, other highly informative metrics (Non-RPG) and both combined
mvOutlier models across various read depths (x-axis ticks) for a given scRNA-Seq dataset.
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Figure S16: 3D plot of RPG features extracted from mouse pancreas dataset.
3D plot showing RPG features in each axis (log scale) for single cell libraries in the mouse pancreas test dataset.
The symbols represent different ground truth QC states defined as per visual inspection and valid biological
markers [131].

7.3 Appendix III – Supplementary tables
Table S1: Log-likelihood and parameter estimates generated from random-site models for RP genes. P =
number of free parameters for each model, ℓ = log-likelihood value for each model.
RPL28:
Models

p

ℓ

Estimates of parameters

M0:one ratio

1

-14664.881

omega=0.223

M1a:nearly neutral

2

-15243.079

p0=0.0001,p1=0.9999,
omega0=0.0001, omega1=1.0000

M2a:positive selection

4

-15168.003

p0=0.0000,p1=0.83519, p2=0.16481
omega0=0, omega1=1, omega3=3.39940

M0, omega=1:fixed omega

4

-15848.007

None
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RPL14:
Models

p

ℓ

Estimates of parameters

M0:one ratio

1

-11320.898

omega=0.348

M1a:nearly neutral

2

-10997.396

p0=0.7266,p1=0.27331,
omega0=0.18668, omega1=1.0000

M2a:positive selection

4

-10962.242

p0=0.71909,p1=0.17451, p2=0.10640
omega0=0.20926, omega1=1, omega3=2.54602

M0, omega=1:fixed omega

4

-12018.938

None

Models

p

ℓ

Estimates of parameters

M0:one ratio

1

-14320.835

omega=0.286

M1a:nearly neutral

2

-14134.842

p0=0.76,p1=0.24,

RPS16:

omega0=0.226, omega1=1

M2a:positive selection

4

-14646.878

p0=0,p1=0.17451, p2=0.10640
omega0=0, omega1=1, omega3=4.65

M0, omega=1:fixed omega

4

-15340.056

None

Models

p

ℓ

Estimates of parameters

M0:one ratio

1

-14320.835

omega=0.328

M1a:nearly neutral

2

-14134.842

p0=0.0001,p1=0.9999,

RPS18:

omega0=0, omega1=1.0000

M2a:positive selection

4

-14646.878

p0=0.8292,p1=0.11455, p2=0.05563
omega0=0.288, omega1=1, omega3=2.19489
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M0, omega=1:fixed omega

4

-176000.284

None
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Table S3: List of sgRNA Pairs Used with Cas9 Nickase to Identify the Optimal Target Site Spacing for
Double Nicking for RPS15 and RPS26 source and duplicate genes. Related to Figure 17.
CRISPR sgRNA Name

Sequence

S15_Source_G1Top

CACCGATCCTCAGAAGAGATCGCTT

S15_Source_G1Bot

AAACAAGCGATCTCTTCTGAGGATC

S15_Source_G2Top

CACCGAGATGGTGAGTGTTGCGATT

S15_Source_G2Bot

AAACAATCGCAACACTCACCATCTC

S15_Duplicate_G1Top

CACCGAAGTAGAGCAGAAGAAGAAG

S15_Duplicate_G1Bot

AAACCTTCTTCTTCTGCTCTACTTC

S15_Duplicate_G2Top

CACCGTCCTCAGAAGAGCAGCATAC

S15_Duplicate_G2Bot

AAACGTATGCTGCTCTTCTGAGGAC
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S26_Source_G1Top

CACCGTGGAGGCACGGACCGGAGAG

S26_Source_G1Bot

AAACCTCTCCGGTCCGTGCCTCCAC

S26_Source_G2Top

CACCGGTGAGTCTTCTTGCGTGGTG

S26_Source_G2Bot

AAACCACCACGCAAGAAGACTCACC

S26_Duplicate_G1Top

CACCGTCTTTGTCATCTTGGAGGCA

S26_Duplicate_G1Bot

AAACTGCCTCCAAGATGACAAAGAC

S26_Duplicate_G2Top

CACCGGAACAATGGTCGTGCCAAAA

S26_Duplicate_G2Bot

AAACTTTTGGCACGACCATTGTTCC

Table S4: List of training and test datasets used in the scRNA-Seq QC pipeline

Dataset_Accession_Num Organism Cell Type

High
Low
Number Quality Quality Low Quality Quality
of Cells Cells
Cells
QC
Check

Training Dataset

E-MTAB-2600 [147]

Mouse

mES cells
grown in
2i,a2i,serum
media
863

Mouse

mES at
different Cell
cycle stages 356

786

77

Multiple:21;
Empty:23;
Dead:34
C1-Visual

28

Multiple:4,
Empty:4,
Dead:20

C1-Visual

345

-

Cell
specific
SVM (80
Genes),
Number of
Reads,
Number of
Reads
Aligned

77

Multiple:9;
Empty:50;
Debris:8
Other QC:
10

C1-Visual
& Other
Metrics

Test Datasets

E-MTAB-2805 [148]

E-GEOD-48968 [149]

RIKEN (unpublished
dataset)

Mouse

Human

bonemarrowderived
dendritic
cells

HELA Cells

1090

356
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328

745

279

E-GEOD-77980 [131]

Mouse

Islet Cells

622

341

281

Multiple:179
Dead: 5
Other QC:
97

C1-Visual
(only dead
cells) &
Other
Metrics

Table S5: Breakdown of performance for mvOutlier across cell quality states in various datasets (A to E)
and different QC feature sets (each table).
Each cell in a table represents combination of ground truth calls (column) and mvOutlier calls (row) of
single cell libraries. The correct combination pair is represented by a green fill background and the
incorrect combination by red fill background. The values in each cell represent classification % by both
methods and actual number of single cell libraries it corresponds to in parenthesis. Different ranges of
correct classification percentages are indicated by the following symbols in each column header, *** >=
95%; ** >=85% & <95% ;* >= 75% & <85%.
C1=Annotated using C1 microfluidic system, Failed Other QC=QC calls based on experiment specific
metrics/widely used metrics (refer to original manuscripts listed in supplementary table 4 for more
details).
A) Mouse Islet cells
RPG metrics

Good** [C1]

Low
Quality 7% (24)
(mvOutlier)
High
Quality 93% (317)
(mvOutlier)

80% (4)

Multiple
(Bio-markers)
15% (26)

20% (1)

85% (153)

56% (44)

Non-RPG metrics

Dead* [C1]

Failed Other QC
***
95% (92)

Good* [C1]

Dead* [C1]

Failed Other QC
54% (53)

Low
Quality 18% (62)
(mvOutlier)
High
Quality 82% (279)
(mvOutlier)

80% (4)

Multiple
(Bio markers)
26% (46)

20% (1)

74% (133)

5% (5)

Combined metrics

Dead* [C1]
80% (4)

Multiple
(Bio markers)
32% (58)

Failed Other QC
***
95% (92)

20% (1)

68% (121)

5% (5)

Good* [C1]

Low
Quality 21% (72)
(mvOutlier)
High
Quality 79% (269)
(mvOutlier)
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B) mES
Good** [C1]
RPG metrics
Low
Quality 15% (54)
(mvOutlier)
High
Quality 85% (302)
(mvOutlier)

Dead [C1]
15% (3)

Empty [C1]
25% (1)

Multiple [C1]
0% (0)

85% (17)

75% (3)

100% (4)

Non-RPG metrics Good** [C1]
Low
Quality 11% (40)
(mvOutlier)
High
Quality 89% (316)
(mvOutlier)

Dead [C1]
15% (3)

Empty [C1]
0% (0)

Multiple [C1]
0% (0)

85% (17)

100% (4)

100% (4)

Good* [C1]
Combined
metrics
Low
Quality 21% (74)
(mvOutlier)
High
Quality 79% (282)
(mvOutlier)

Dead [C1]

Empty [C1]

Multiple [C1]

20% (4)

25% (1)

0% (0)

80% (16)

75% (3)

100% (4)

C) Hela cells

Low
Quality 12% (34)
(mvOutlier)
High
Quality 88% (245)
(mvOutlier)

38% (3)

Empty***
[C1]
98% (49)

62% (5)

2% (1)

89% (8)

40% (4)

Non-RPG metrics Good* [C1]

Dead/Debris [C1]
13% (1)

Multiple
[C1]
0% (0)

Failed Other QC

Low
Quality 20% (55)
(mvOutlier)
High
Quality 80% (224)
(mvOutlier)

Empty**
[C1]
90% (45)

87% (7)

10% (5)

100% (9)

50% (5)

RPG metrics

Good** [C1]

Dead/Debris [C1]
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Multiple
[C1]
11% (1)

Failed Other QC
60% (6)

50% (5)

Good* [C1]
Combined
metrics
Low
Quality 25% (69)
(mvOutlier)
High
Quality 75% (210)
(mvOutlier)

Dead/Debris
[C1]

Empty***
[C1]

Multiple
[C1]

Failed Other QC

25% (2)

98% (49)

11% (1)

60% (6)

75% (6)

2% (1)

89% (8)

40% (4)

D) Mouse dendritic cells

RPG metrics
Low Quality (mvOutlier)
High Quality (mvOutlier)

Good (SVM)***
5.5 % (41)
95.5% (704)

Bad (SVM)*
83%(287)
17% (58)

Non-RPG metrics
Low Quality (mvOutlier)
High Quality (mvOutlier)

Good (SVM)
27% (204)
73% (541)

Bad (SVM)
45% (155)
55% (190)

Combined metrics
Low Quality (mvOutlier)
High Quality (mvOutlier)

Good (SVM)***
5.5 % (41)
95.5% (704)

Bad (SVM)*
83%(287)
17% (58)

E) Training mES Cells
Good** [C1]
RPG metrics
Low
Quality 8% (65)
(mvOutlier)
High
Quality 92% (721)
(mvOutlier)

Dead [C1]

Empty** [C1]

Multiple [C1]

38% (13)

83% (19)

19% (4)

62% (21)

17% (4)

81% (17)

Non-RPG metrics Good [C1]
Low
Quality 33% (257)
(mvOutlier)
High
Quality 67% (529)
(mvOutlier)

Dead** [C1]

Empty** [C1]

Multiple [C1]

94% (32)

87% (20)

71% (15)

6% (2)

13% (3)

29% (6)
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Good [C1]
Combined
metrics
Low
Quality 34% (270)
(mvOutlier)
High
Quality 66% (516)
(mvOutlier)

Dead** [C1]

Empty** [C1]

Multiple [C1]

94% (32)

87% (20)

71% (15)

6% (2)

13% (3)

29% (6)

7.4 Appendix IV – Authored publication
1) Tempo and Mode of Gene Duplication in Mammalian Ribosomal Protein Evolution
Citation: Obla, A., Dharia, A. P., Gajdosik, M. D., Simon, A. & Nelson, C. E. Tempo and Mode of
Gene Duplication in Mammalian Ribosomal Protein Evolution. PLoS One (2014)
Abstract: Gene duplication has been widely recognized as a major driver of evolutionary change
and organismal complexity through the generation of multi-gene families. Therefore,
understanding the forces that govern the evolution of gene families through the retention or
loss of duplicated genes is fundamentally important in our efforts to study genome evolution.
Previous work from our lab has shown that ribosomal protein (RP) genes constitute one of the
largest classes of conserved duplicated genes in mammals. This result was surprising due to the
fact that ribosomal protein genes evolve slowly and transcript levels are very tightly regulated.
In our present study, we identified and characterized all RP duplicates in eight mammalian
genomes in order to investigate the tempo and mode of ribosomal protein family evolution. We
show that a sizable number of duplicates are transcriptionally active and are very highly
conserved. Furthermore, we conclude that existing gene duplication models do not readily
account for the preservation of a very large number of intact retroduplicated ribosomal protein
(RT-RP) genes observed in mammalian genomes. We suggest that selection against dominant-
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negative mutations may underlie the unexpected retention and conservation of duplicated RP
genes, and may shape the fate of newly duplicated genes, regardless of duplication mechanism.
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